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Temporal Expression of Key Angioregulatory Proteins in  
Response to Exercise and Detraining 
 
Sara A. Olenich 
 
Angiogenesis is an important adaptation to exercise, occurring in response to a 
multitude of different stimuli including: shear stress, mechanical stretch, ischemia, electrical 
stimulation, and exercise. Current thinking suggests skeletal muscle angiogenesis is a temporal 
process controlled by a balance between positive and negative angiogenic proteins. But there is 
limited information on what molecular mediators control skeletal muscle angiogenesis in this 
time line, creating a critical need to clarify how individual protein responses regulate physiologic 
skeletal muscle angiogenesis in response to exercise training and/or physical deconditioning. 
Our objective is to characterize the temporal expression of several key positive (VEGF, MMP-2, 
MMP-9, nucleolin) and negative (TSP-1, endostatin) angiogenic factors under basal conditions, 
after acute exercise, in response to training, and after detraining. The central hypothesis is that 
training and deconditioning will cause temporally coordinated changes in positive and negative 
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CHAPTER 1: INTRODUCTION 
Increasing skeletal muscle vascularity in active muscle is recognized to be important in 
improving the surface area on which substrate/metabolism/oxygen exchange can take place in 
order to meet the high metabolic demands (of skeletal muscle) imposed during periods of 
increased physical activity (Snyder 1987, Wagner, Roca et al. 1990, Snyder, Farrelly et al. 
1992, Wagner 1996, Mathieu-Costello and Hepple 2002, Howlett, Kirkton et al. 2008). Under 
normal conditions endothelial cells, the cells which line blood vessels, have a slow turnover rate 
of about a thousand days, but when called upon, such as in wound healing, endothelial cells 
can turnover in five days (Folkman and Shing 1992).  Likewise, exercise can induce significant 
changes of skeletal muscle capillarity in 7 days (mouse) (Waters, Rotevatn et al. 2004) or as 
little as 2-4 days (rabbit) when electrically stimulated for 8 hours a day (Brown, Cotter et al. 
1976). The growth of vasculature occurs relatively quickly, which is important to meet the 
increased demand of skeletal muscle. Yet, more fascinating than the speed of angiogenesis is 
the temporal coordination and organization of numerous pro and anti angiogenic mitogens in 
order for sprouting vessels to form without overt vascular disruption.   
Understanding  the temporal expression patterns of essential angiogenic peptides, such 
as vascular endothelial growth factor (VEGF), matrix metalloproteinase (MMP) -2, MMP-9, 
nucleolin, endostatin, and thrombospondin-1 (TSP-1) in response to angiogenic-inducing stimuli 
(e.g. exercise) is needed to better understand the physiologic regulation of angiogenesis. For 
example, VEGF stimulates vascular permeability allowing for extravasation of plasma proteins, 
endothelial cell proliferation, migration, and adhesion for vessel lumen formation. Nucleolin may 
help mediate VEGF to the nucleus while presence of MMP-2 and MMP-9 are needed to disrupt 
the extracellular matrix surrounding the existing vessel in order to accommodate the new 
vascular outcropping (Huang, Shi et al. 2006). Plasma proteins, including fibrinogen and 
plasminogen, escape the blood stream through permeable vessels and are capable of initiating 
a basic scaffold on which endothelial cells begin can migrate and to form a cord or tube-like 
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structure. After lumen formation the vessels are still unstable until mural cells migrate in and 
differentiate into pericytes or smooth muscle cells. As patent vessels are formed, withdrawal 
and/or inhibition of the pro-angiogenic signals are needed for maturation and stabilization of 
nascent vessels.  Negative regulators (e.g. TSP-1, endostatin) are able to inhibit pro-angiogenic 
pathways by inhibiting factors such as VEGF. Endostatin, a fragment of collagen XVIII, may also 
prevent microvascular growth by down regulating proangiogenic and up regulating antiangiogic 
factors (Kim, Hwang et al. 2002, Abdollahi, Hahnfeldt et al. 2004, Cao 2008). The complex 
balance of pro- and anti-angiogenic proteins is thought to trigger the growth or regression of 
capillaries.  
 
VASCULAR ENDOTHELIAL GROWTH FACTOR 
VEGF-A, VEGF-B, VEGF-C and VEGF-D comprise the VEGF family and are recognized 
by the receptors VEGFR1 (Flt-1), VEGFR2 (KDR/Flk-1) and VEGFR3 (Flt-4) (Robinson and 
Stringer 2001). VEGF-A, a ~45kDa protein, is the most biologically important in angiogenesis 
and is generally referred to as VEGF (Ferrara and Henzel 1989, Hoeben, Landuyt et al. 2004). 
In the human genome, VEGF has eight exons which are differentially spliced (between 18 and 
24 kDa) to VEGF121, VEGF165, VEGF189, and VEGF206 with the most bioactive form being 
VEGF165 (Tischer, Mitchell et al. 1991, Park, Keller et al. 1993, Roskoski Jr 2007). VEGF mRNA 
half-life has been reported to be about an hour with an increase reported in response to hypoxia 
in cell culture (Levy, Levy et al. 1996) and recombinant VEGF has a half-life of 33.7±13 minutes 
in human plasma (Eppler, Combs et al. 2002). With short half-life’s, proteins such as heparin 
sulphate proteoglycans and neuropilin-1 have the ability to prolong VEGF biological activity or 
enhance receptor binding (Robinson and Stringer 2001). VEGF can also be found bound to the 
ECM (Ferrara and Henzel 1989, Tischer, Mitchell et al. 1991, Park, Keller et al. 1993). When 




VEGF has long been associated with an increase of vascular permeability of blood 
vessels, and in fact was originally known as vascular permeability factor (Senger, Connolly et al. 
1990, Dvorak 2002).  However, the vitality of the gene was demonstrated when attempting to 
create a total body VEGF KO mouse –where the loss of  a single  allele was embryonically 
lethal due to poorly formed vasculature development in utero (Ferrara, Carver-Moore et al. 
1996). A myocyte-specific VEGF KO mouse has been successfully generated and displayed a 
significant reduction in C:F ratio (39% decrease) and exercise performance, e.g.  reduced 
maximal running speed (by 34%) and reduced endurance capacity (by 81%) compared to 
controls (Olfert, Howlett et al. 2009). Furthermore, skeletal muscle capillarity in myocyte-specific 
VEGF KO mice did not adapt to exercise training as typically seen in exercise trained wild-type 
mice (Olfert, Howlett et al. 2010). VEGF receptor antagonism also partially inhibits training 
induced skeletal muscle angiogenesis in ischemia induced hindlimb muscles of mice (Lloyd, 
Prior et al. 2005). Another study which sequestered VEGF using VEGF Trap prevented 
increases in skeletal muscle angiogenesis induced  by shear stress (e.g. increase blood flow) or 
muscle stretch/overload conditions (Williams, Cartland et al. 2006). These studies showed that 
not only is VEGF critical to vascular development in utero but also in response to exercise 
training. 
Short term training (7 days) in humans has been positively correlated with an increase of 
VEGF mRNA in skeletal muscle (Gustafsson, Knutsson et al. 2002). Similar results were 
reported in rats: VEGF mRNA was elevated after each day of exercise when exercising on a 
treadmill for one hour a day, for five days (Gavin and Wagner 2001). In another study the effects 
of detraining were also evaluated in cardiac muscle of rats. Rat VEGF mRNA was investigated 
in control, trained (10 weeks of treadmill training, 30 hours of total training), and detrained rats 
(4 weeks). (Marini, Falcieri et al. 2008) VEGF mRNA and cardiac capillary density were 
elevated after training but those responses returned to control levels after four weeks of 
detraining (Marini, Falcieri et al. 2008). In a time course study where rats treadmill trained, 
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VEGF mRNA had the largest fold change in the white GA, but the SOL and red portion of GA 
had several time points (3-21 days) at which VEGF mRNA was significantly elevated too (Lloyd, 
Prior et al. 2003). Although there is a strong trend for an increase in VEGF mRNA and protein in 
response to exercise, not all studies show this. One example is where participants trained on a 
bicycle ergometer for four weeks (Hoier, Nordsborg et al. 2012). After cycling, there was an 
increase of C:F ratio but VEGF protein at basal conditions were not different before or after the 
training period, but perhaps the window of peak expression/training adaptation had passed by 
four weeks (Hoier, Nordsborg et al. 2012).  
An acute bout of exercise is known to elicit an increase of VEGF mRNA (Olfert, Breen et 
al. 2001, Hoier, Nordsborg et al. 2012). However, there are mixed results as to whether the 
acute response remains in a trained and/or detrained state. In a human population that trained 
on a cycle ergometer for four weeks, VEGF protein was elevated in response to acute exercise 
both before and after four weeks of training (Hoier, Nordsborg et al. 2012). However, the acute 
response to exercise in rats that trained for 10 weeks was lost, but returned after 7 days of 
detraining in the plantaris but not soleus muscle (Malek, Olfert et al. 2010). However, 
discrepancies between mRNA expression in response to acute exercise may be due to species 
and fiber type. 
 
MATRIX METALOPROTEINASE -2 AND -9 
There are at least 20 MMP’s known to participate in processes such as proteolytic 
degradation of the ECM and basement membranes (Nagase and Woessner 1999). Degradation 
is necessary to destabilize current vasculature and ECM allowing for outcroppings of new 
vessels. However, the activities of MMP’s are highly regulated to preserve the integrity of matrix 
surrounding the vasculature which would be compromised if left unchecked. MMP’s are 
regulated at three key steps. First, DNA must be transcribed into mRNA and translated into an 
inactive proMMP. Second, proMMP’s require enzymatic cleavage to become a mature MMP. 
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Third, mature MMP’s can be inhibited by tissue inhibitor of metalloproteinase (TIMPS). There 
are several subclasses of MMP’s but one subclass of particular interest is collagenase which 
harbors the gelatinases: MMP-2 (collagenase A or pro-MMP, 72kDa; active MMP-2, 62kDa) and 
MMP-9 (collagenase B, 92kDa; active MMP-9 82kDa) (Schmalfeldt, Prechtel et al. 2001, 
Shimokawa, Katayama et al. 2002). Gelatinases are instrumental in angiogenesis due to their 
ability to degrade the most prevalent protein in skeletal muscle basal lamina: collagen IV. 
There is strong evidence that MMP-2 and MMP-9 are critical for angioadaptation. MMP-
2 has been localized to the ECM around muscle fibers, capillaries, and inside the muscle fiber 
(Rullman, Norrbom et al. 2009) and is involved with cell fusion (Zimowska, Brzoska et al. 2008). 
Pharmacological inhibition of MMP activity prevents capillary adaptation in chronic electrically 
stimulated hindlimb muscles, demonstrating that MMP activity is required for skeletal muscle to 
undergo capillarity adaptation in response to chronic muscle contractions (Haas, Milkiewicz et al. 2000). 
MMP-9 is localized to capillaries and around muscle fibers without expression in muscle fibers (Rullman, 
Norrbom et al. 2009), may be involved in myoblast cell differentiation (Zimowska, Brzoska et al. 2008), 
plays a role in collagen assembly and compaction (Whatling, McPheat et al. 2004) and inhibition of 
MMP-9 inhibits endothelial cell migration (Jadhav, Chigurupati et al. 2004). Both MMP-2 and MMP-9 are 
more abundant in zones where cellular differentiation occurs and participate in smooth muscle cell 
migration and neointima growth (Whatling, McPheat et al. 2004). The activity of MMP’s may be, in part, 
dependent on the angiogenic stimulus. For example MMP-2 protein levels can be increased with 
muscle stretch by unilateral extirpation of the tibalis anterior but not in response to an increase 
in circulating blood flow and increases in shear stress induced by prazosin (Rivilis, Milkiewicz et 
al. 2002). The same authors reported no significant change of MMP-9 under either condition 
(Rivilis, Milkiewicz et al. 2002); however, MMP-9 may be involved in arterialization (20>μm 
diameter) with administration of prazosin (van Gieson and Skalak 2001).  
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The effects of a protein can be observed when knocking it out in a mouse model. MMP-2 
and MMP-9 null mice both are fertile but subtle differences were noted. MMP-2 KO mice tended 
to be about 15% smaller than littermates (Itoh, Ikeda et al. 1997) and had a slower angiogenic 
response and tumor growth rate than littermate controls (Itoh, Tanioka et al. 1998). MMP-9 KO 
mice showed delayed angiogenesis in bone growth plates (Itoh, Ikeda et al. 1997), did not stop 
tumor growth (Masson, de la Ballina et al. 2005), and had slower smooth muscle cell 
proliferation and migration in arteries (Cho and Reidy 2002). Interestingly, knocking out MMP-2 
or MMP-9 individually was not sufficient to arrest tumor growth/angiogenesis but when both 
were knocked out in the same mouse, tumor growth was halted (Masson, de la Ballina et al. 
2005), possibly implicating that they work together. However, other studies make convincing 
arguments that MMP-9 appears to be a larger contributor and possibly a switch that triggers the 
activation of quiescent vasculature (Bergers, Brekken et al. 2000, Bergers and Benjamin 2003); 
whereas MMP-2 may play a minor role in growth of new vasculature (Bergers, Brekken et al. 
2000). 
MMP-2 and MMP-9 have different expression profiles and have been evaluated under 
basal conditions and in response to acute exercise but the temporal response is still unclear. 
Under basal conditions in mouse skeletal muscle, MMP-2, but not MMP-9, mRNA and protein is 
normally expressed (Kherif, Lafuma et al. 1999). With acute exercise, one study saw a decrease 
of MMP-2 proMMP-2 immediately after exercise (Koskinen, Heinemeier et al. 2004), another 
study reported an increase of MMP-2 protein only at 30 min post cycling (Suhr, Brixius et al. 
2007), a third study saw no increase of protein under basal conditions in long and short track 
athletes pre season but reported an increase 1 hour post acute exercise in long track athletes 
(Suhr, Rosenwick et al. 2010). MMP-2 was evaluated up to 3 days after acute exercise on a 
treadmill, levels were low immediately and 1 day after exercise but were elevated 3 days post 
exercise (Koskinen, Heinemeier et al. 2004).  Meanwhile, MMP-9 has been reported to be 
elevated 0-4 hours post acute exercise (Koskinen, Heinemeier et al. 2004, Suhr, Brixius et al. 
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2007, Suhr, Rosenwick et al. 2010) and remained elevated at 1 and 3 days post acute exercise 
(Koskinen, Heinemeier et al. 2004). In response to a season of training, MMP-9 serum levels 
tended to be lower in both short and long track athletes under basal conditions and after acute 
exercise, but MMP-2 levels were not affected by training (6 months) (Suhr, Rosenwick et al. 
2010). In short, MMP-2’s response to acute exercise has yet to be fully understood but MMP-9 
has an immediate increase of protein levels that remain for at least 3 days but dissipates with 
chronic training. 
There have been a number of articles published in a human model about MMP-2 and 
MMP-9 protein expression in response to acute exercise but there are fewer articles about 
chronic exercise. One study reported ten days of high intensity running elevated MMP-9 mRNA 
in rat GA and SOL (Carmeli, Haimovitz et al. 2007). Single leg training in humans, also resulted 
in an increase of MMP-9 mRNA taken from a muscle biopsy at 10 and 35 days, but MMP-9 
protein remained unchanged (Rullman, Norrbom et al. 2009). In the same single leg study, 
MMP-2 mRNA levels were significantly elevated after 10 and 35 days of training but only had 
increased protein levels at day 10 (Rullman, Norrbom et al. 2009). These two studies suggest 
that MMP-2 mRNA is elevated with increasing exercise duration where as MMP-9 is not. Many 
of the studies evaluated serum and plasma levels but examination of protein expression in the 
skeletal muscle where angiogenesis occurs is needed.  
 
NUCLEOLIN 
Nucleolin (formally known as C23) is a 105 kDa nuclear multifunctional protein which plays a 
role in many different cellular actions including cell proliferation, ribosome biogenesis, 
mitogenesis, adhesion, and differentiation (Andersen, Lam et al. 2005, Destouches, El Khoury 
et al. 2008). Furthermore, nucleolin, a major nuclear protein in cells that proliferate exponentially 
(Lapeyre, Bourbon et al. 1987), also serves as a shuttle between the nucleus, cytoplasm, and 
cell surface (Borer, Lehner et al. 1989, Schmidt-Zachmann, Dargemont et al. 1993, 
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Hovanessian, Soundaramourty et al. 2010), binds to DNA with high affinity (Chen, Chiang et al. 
1991), can control the unwinding of DNA and RNA duplexes (Tuteja, Huang et al. 1995), and 
angiogenesis (Destouches, El Khoury et al. 2008). Nucleolin is exclusively a self cleaving 
fragment (cleaved at 6 hours, completely degraded at 24 hours) but is inhibited by an 
unidentified proteolytic inhibitor in the nuclei (Chen, Chiang et al. 1991). The unidentified 
inhibitor is negatively charged and binds to an enzymatic domain found in the two thirds side of 
the C-terminal (Fang and Yeh 1993). When  using agonist HB-19 pseudopeptide which binds to 
the C-terminal of cell surface nucleolin, tumor growth and angiogenesis has been halted both in 
vivo and in vitro with no toxicity to normal tissue (Destouches, El Khoury et al. 2008). Inhibition 
of nucleolin in cell culture inhibited migration but did not affect proliferation or adhesion (Huang, 
Shi et al. 2006). The presence of nucleolin on the cell surface is highly correlated with cell 
growth conditions in cell culture (Hovanessian, Soundaramourty et al. 2010); degraded nucleolin 
quantities gradually decrease as cells start to become more proliferative (Chen, Chiang et al. 
1991). Nucleolin, with its strong correlation to cell proliferation, has been used as a marker of 
angiogenic endothelial cells in tumor blood vessels (Christian, Pilch et al. 2003). When anti-
nucleolin antibody was injected into mice, the antibody only accumulated on the surface of 
tumor blood vessels (Shi, Huang et al. 2007). These points emphasize the close connection 
between nucleolin expression and angiogenesis, indicating nucleolin might serve as a critical 
angiogenic biomarker for proliferating endothelial cells. 
Due to the strong correlation of nucleolin and angiogenesis and a lack of articles 
evaluating it in response to acute exercise or training, we believe that further evaluation of the 
protein in skeletal muscle angiogenesis is warranted.   
 
ENDOSTATIN 
Endostatin is a 22kDa anti-angiogenic C-terminal fragment of collagen XVIII found 
throughout the body with most of the monomer being prevalent in the vascular and epithelial 
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basal membrane around muscular structures (Faye, Chautard et al. 2009). Endostatin is an 
effective inhibitor of angiogenesis by restricting endothelial cell proliferation and migration by 
inducing apoptosis, down-regulating pro-angiogenic signaling pathways and up-regulating anti-
angiogenic genes (Kim, Hwang et al. 2002, Abdollahi, Hahnfeldt et al. 2004, Cao 2008). Since 
endostatin is derived from collagen matrix, its formation is dependent not on transcription but by 
other regulators such as MMP-9, elastase, and cathepsin L which cleave the fragment from 
collagen XVIII (Wen, Moses et al. 1999, Felbor, Dreier et al. 2000, Chang, Javier et al. 2005, 
Heljasvaara, Nyberg et al. 2005). MMP’s known to produce the endostatin fragment are MMP-3, 
-7, -9, -13, -20, whereas MMP-1, -2, -8 and -12 do not (Heljasvaara, Nyberg et al. 2005). A cell 
culture study suggests that generation of endostatin may be a two step process. The first step is 
metal dependent, which trims collagen XVIII to NC1 [69]. The second step of endostatin 
generation is elastase dependent, elastase cleaves NC1 to endostatin (Wen, Moses et al. 
1999). Endostatin KO mice, also known as Col18a1 KO mice, do not have an abnormal 
increase of capillarity in most organs and tumor growth is not increased in these mice, however 
aortic implants from KO mice into WT mice had increased microvessel growth (Li and Olsen 
2004) the mice may also have ocular abnormalities due to abnormal retinal vessel growth 
(Marneros and Olsen 2005).   
The endostatin fragment works by blocking general mechanisms that influence 
endothelial cell growth including interfering with VEGFR2 receptors (Kim, Hwang et al. 2002, 
Lee, Jang et al. 2002, Cao 2008). An exception to its antiangiogenic activity would be during 
embryonic development where it may operate in an angio-modulatory way. (Kim, Hwang et al. 
2002, Schmidt, Wenzel et al. 2004, Cao 2008) Interestingly, endostatin does not act solely by 
inhibiting pro-angiogenic proteins but also up regulates anti-angiogenic proteins (Abdollahi, 
Hahnfeldt et al. 2004). For example, endostatin can up regulate TSP-1 and simultaneously 
down regulating the TSP-1 suppressor ID-1 (Volpert, Pili et al. 2002). Endostatin does more 
than just modulate TSP-1, it is capable of affecting a wide range of proteins. DNA and antibody 
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array technology have shown that endostatin, when administered as a drug, is capable of 
inhibiting 65 varieties of tumor and modified 12% of the human genome in human dermal 
microvascular endothelial cells (mostly angiogenic pathways) (Abdollahi, Hahnfeldt et al. 2004).  
 Endostatin concentrations appear to vary due to tissue oxidative capacity. Under basal 
conditions, the heart has 4.9 times lower endostatin and 1.5 higher VEGF protein level than the 
anterior tibialis, which correlates with the heart having a greater capillarity density. However 
after rats exercised for three weeks, there was nearly a 3 fold decrease of endostatin and 2 fold 
increase of VEGF in the TA (Gu, Shparago et al. 2006).  
 Endostatin has been well characterized in tumor research but there are limited articles 
about its regulation and expression in skeletal muscle in response to exercise. During acute 
exercise, circulating levels of endostatin increased in a linear relationship to peak VO2 
(R2=.9388) (Gu, Gadonski et al. 2004), but exercise did not increase endostatin levels in plasma 
with increasing time exercising at 50-65% of VO2 max (Rullman, Rundqvist et al. 2007). In 
response to acute exercise, endostatin is significantly elevated at 0 hours post exercise(Suhr, 
Brixius et al. 2007). Endostatin levels were reduced after training basally and in response to 
acute exercise in both elite short and long track athletes (Suhr, Rosenwick et al. 2010). Another 
study measured VEGF and endostatin concentrations pre and post 6 months of training and 
found VEGF levels were not affected but training significantly reduced endostatin levels (Brixius, 
Schoenberger et al. 2008). In short, endostatin plasma levels seem to be elevated in response 
to acute exercise: the harder the workload (working at a higher VO2), the higher the endostatin 
level. These studies imply that endostatin correlates with intensity (VO2) of acute exercise and 
decreases with chronic training, but the temporal response of endostatin to training and 







TSP-1 is a large, 450 kDa trimeric, extracellular matrix glycoprotein. It is produced by 
several different cell types including α-granules, smooth muscle cells, endothelial cells, 
fibroblasts, kerationocytes, neutrophils and macrophages (Duffield 2003, Olfert and Birot 2011). 
TSP-1 is effective by inhibiting endothelial cell proliferation, adhesion, and motility 
(Bagavandoss and Wilks 1990, Taraboletti, Roberts et al. 1990).  TSP-1 can inhibit the 
angiogenic response by binding to CD47 which in turn inhibits VEGFR2’s phosphorylation and 
thus downstream targets (Isenberg, Frazier et al. 2008, Kaur, Martin-Manso et al. 2010). The 
protein may not be needed in large quantities to inhibit angiogenesis under basal conditions, as 
pM concentrations in plasma appears to be sufficient (Isenberg, Frazier et al. 2008).  
 The first mouse strain used to produce TSP-1 KO mice were 129Sv background mice, 
which exhibited increased levels of white blood cells, lordotic curvature of the spine, and had 
lung abnormalities making them susceptible to pneumonia (Lawler, Sunday et al. 1998). This 
phenotype has not manifested in C57Blk6 strain of TSP-1 KO mice which are currently 
commercially available.  Recent evidence have found the C57Blk6 TSP-1 KO to have greater 
microvessel density compared to wild-type mice under basal conditions (Fitchev, Wcislak et al. 
2010). These TSP-1 KO mice also had 67% increased in endurance running test and an 11% 
increase in maximal running speed, which can likely be attributed to significant increase of 
skeletal and cardiac muscle capillarity (Malek and Olfert 2009). 
 There are only a few studies that examine TSP-1 in response to exercise or training. 
TSP-1 mRNA expression was examined after training rats for one hour a day up to five days. 
The study found that mRNA was elevated from basal conditions only on days one and two, and 
returned to baseline conditions on days 3-5 (Olfert, Breen et al. 2006). After chronic exercise 
consisting of  four weeks of bicycle ergometer training, an increase of C:F ratio was reported but 
VEGF and TSP-1 protein at basal conditions were not remarkable before and after the training 
period (Hoier, Nordsborg et al. 2012). The lack of TSP-1 response may be due to the time 
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points selected for samples to be taken, for example, peak expression may have been at day 3 
which fell between the 0 and 4 week time points. The cycling study also examined acute 
response to exercise under basal and trained states and showed TSP-1 mRNA had an acute 
response at one and three hours post exercise under basal and trained conditions (Hoier, 
Nordsborg et al. 2012). Finally, TSP-1 expression can be altered with other compounds such as 
(-)-epicatchin found in cacao. When (-)-epicatchin was administered in mouse drinking water, 
TSP-1’s response following training was blunted preventing a loss of capillarity; TSP-1 levels 
remained at a trained state even though mice were detraining (Hüttemann, Lee et al. 2011). 
Angiogenesis research has largely examined proangiogenic proteins but antiangiogenic proteins 
including TSP-1 may also play an equally important of a role in regulating capillary growth and 
development and therefore their response need to better characterized. 
 
INTEGRATED ANGIOGENIC PROTEIN RESPONSE TO EXERCISE 
Collectively the review of VEGF, MMP-2, MMP-9, nucleolin, endostatin, and TSP-1 highlight 
their individual importance in the angiogenic process, however, there is a deficiency of 
knowledge of how these proteins respond to physiologic stimuli that alter vascular networks 
such as acute exercise, training and/or detraining. The current proposal examines the temporal 
expression (basal and time course response to acute exercise) of these factors in conjunction 
with morphological changes in skeletal muscle capillarity in mice at differing time points up to 28 
days of voluntary exercise training, and at various time points up to 28 days after detraining, in 
order to gain further insight in the temporal regulation of capillary expansion and rarefaction. But 
it also is important to note that these factors may interact and influence each other. Below is as 
summary of the known effects of each factor with one another, or other potential angioregulatory 
factors.  Identifying the potential temporal associations or links between these individual 
angiogenic may help to more clearly understand the physiologic regulation of exercise-induced 




 VEGF is capable of activating MMP-2 in isolated endothelial cells (Rivilis, Milkiewicz et 
al. 2002), and inhibition of MMP-2 by RNAi decreased VEGF protein (by decreasing 
integrin αVβ3 mediated inhibition of the PI3k/AKT pathway)(Chetty, Lakka et al. 2010). 
 MMP-9 is capable of releasing angiogenic factors including VEGF making them more 
bioavailable (Bergers, Brekken et al. 2000, Giraudo, Inoue et al. 2004, Lee, Jilani et al. 
2005) and in a positive feedback mechanism, VEGF can also up regulate MMP-9 (Wang 
and Keiser 1998, Giraudo, Inoue et al. 2004). 
 VEGF mediates nucleolin mobilization from the nucleus to the endothelial cell surface; 
without VEGF, nucleolin quickly disappears from the cell surface (Huang, Shi et al. 
2006). 
 Endostatin levels in TA have been reported to be inversely correlated with capillary 
density and VEGF levels (Gu, Shparago et al. 2006). Furthermore, several different 
models have shown that endostatin in capable of inhibiting VEGF (Yamaguchi, Anand-
Apte et al. 1999, Wang, Xu et al. 2007, Hu, Xia et al. 2012). One method includes 
inhibiting the KDR/Flk1 VEGF receptor (Kim, Hwang et al. 2002) and another may be 
mediation of endostatin and VEGF by nucleolin. (Huang, Shi et al. 2006, Shi, Huang et 
al. 2007) 
 TSP-1 can interact directly to inhibit VEGF by ligating the VEGFR2 receptor and 
inhibiting phosphorlation,  It can also displace VEGF from a mutual heparin binding site 
on endothelial cells (Gupta, Gupta et al. 1999) 
 
Nucleolin: 
 The interaction between nucleolin and endostatin could be a crucial element for cell 
proliferation and ultimately angiogenesis; heparin binding site of endostatin is critical for 
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nucleolin to bind (Shi, Huang et al. 2007). Nucleolin and endostatin are often found co-
localized on the cell surface but once endostatin is transported to the nuclei via 
nucleolin, endostatin phosphorylates nucleolin inhibiting its role in cell proliferation (Shi, 
Huang et al. 2007). 
 The pseudopeptide HB-19 which inhibits cell surface nucleolin also causes a down 
regulation of VEGF and MMP-2 in cell culture and ultimately suppress tumor growth 
(Krust, El Khoury et al. 2011). 
 Nucleolin is capable of binding to the 3’ region of MMP-9 mRNA, stabilizing it for 
translation and leading to an increase in the degradation of ECM but does not appear to 
participate in the same binding function for MMP-2 (Fähling, Steege et al. 2005). 
 
MMP-2 and MMP-9 
 Both are gelatinases but have their own identity. When knocking out MMP-2 or MMP-9 
individually, neither was individually able to stop tumor growth/angiogenesis but when 
both of these MMP’s were knocked out in the same mouse, tumor growth was halted 
(Masson, de la Ballina et al. 2005) 
 Endostatin may be cleaved by several MMP’s including MMP-9 (Heljasvaara, Nyberg et 
al. 2005).  Endostatin inhibits activity of proMMP-2 (Kim, Hwang et al. 2002). 
 TSP-1 has been shown to increase MMP-2 (Lee, Esemuede et al. 2003) and MMP-9 
(Albo, Shinohara et al. 2002) activation in cell culture. 
Endostatin: 
 TSP-1 shares common cell surface binding ligands with endostatin: α5β1 and αvβ3 
(Sipes, Krutzsch et al. 1999, Rehn, Veikkola et al. 2001). Furthermore, endostatin can 
up regulate TSP-1 and simultaneously down regulating the TSP-1 suppressor ID-1 
(Volpert, Pili et al. 2002). 
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It can be concluded that VEGF, MMP-2, MMP-9, nucleolin, endostatin and TSP-1 all 
play a role in angiogenesis and often have a relationship with each other.  Much of the inference 
between proteins has been implicated by cell culture and tumor research, it has yet to be 
elucidated if similar associations occur in response to exercise-induced skeletal adaptation. The 
current proposal seeks to better understand the relationship between these factors by 
























Specific Aim 1: Examine the temporal expression of key positive and negative 
angiogenic regulators in skeletal muscle in response to acute exercise. 
H1.1: We hypothesize that both positive (e.g. VEGF, MMP-2, MMP-9, nucleolin) and negative 
(e.g. TSP-1, endostatin) angiogenic factors will be elevated in response to a single bout of 
exercise. 
 
Specific Aim 2: Examine the temporal expression of key positive and negative 
angiogenic regulators in skeletal muscle in response to training as well as the 
responsiveness of the factors to acute exercise immediately following training. 
H2.1: We hypothesize the basal expression of positive factors will remain elevated, while basal 
expression of negative factors will decrease, with increasing temporal exposure to training. 
H2.2: We hypothesize the acute exercise response of positive, but not negative, angiogenic 
regulators will be blunted or lost following exercise training. 
 
Specific Aim 3: Examine the temporal expression of key positive and negative 
angiogenic regulators in skeletal muscle in response to detraining and as well as the 
responsiveness of these factors to acute exercise following detraining. 
H3.1: We hypothesize there will be an increase in negative, relative to positive, angiogenic 
factors with detraining. 
H3.2: We hypothesize the blunted acute response of positive angiogenic regulators to exercise 
following training will return after detraining. 
H3.3: We hypothesize that oxidative muscles will have greater changes in angiogenic regulators 
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Angiogenesis is controlled by a balance between positive and negative angiogenic 
factors, but temporal protein expression of many key angiogenic regulators in response to 
exercise are still poorly defined. We evaluated the skeletal muscle temporal expression of pro-
angiogenic vascular endothelial growth factor (VEGF), matrix metalloproteinases (MMP)-2, 
MMP-9, and nucleolin; as well as the anti-angiogenic factors thrombspondin-1 (TSP-1) and 
endostatin, in response to acute and chronic exercise involving 3, 5, 7, 14, or 28 (d)ays of 
voluntary wheel run training. Protein expression of VEGF, endostatin and nucleolin were 
increased 2-4 hours after a single exercise bout; whereas MMP-2 was elevated between a 12-
24 hour window (p<0.05). In response to training, muscle capillarity was increased after 7d, 14d 
and 28d training (p<0.01).  Surprisingly, basal VEGF and MMP-2 were significantly lower with 
3d training, and basal MMP-9 was lower with 5d, 7d and 14d training (p<0.05).  However, 7d 
training significantly increased basal VEGF and MMP-2 compared to 3d training (p<0.05).  
Basal muscle TSP-1 in 14d and 28d trained mice were significantly greater compared to 5d and 
7d trained (p<0.05), and tended to increase compared to basal control levels (p<0.10).  The 
acute responsiveness of VEGF (as seen in untrained mice) was lost after 7d training. Taken 
together, these data support the notion that skeletal muscle angiogenesis is controlled by a 
balance between positive and negative mitogens, and reveals a complex, highly-coordinated, 
temporal scheme whereby these factors can differentially influence capillary growth in response 
to acute versus chronic exercise. Given the multitude of angioregulatory factors that may be 
involved in regulating skeletal muscle angiogenesis, additional studies examining the temporal 
response of each potential angiogenic factor will be necessary before a full understanding of the 







High metabolic demands imposed by exercise on skeletal muscle during physical activity 
are known to elicit cardiovascular adaptations. Among the adaptations induced by exercise 
training is the expansion of skeletal muscle vascularity, which is recognized to be an important 
means of increasing conductance of oxygen within the exercising muscle (Snyder, 1987; Snyder 
et al., 1992; Wagner, 1996; Mathieu-Costello & Hepple, 2002; Howlett et al., 2009). Accordingly, 
there has been much interest in identifying the factors and mechanisms regulating skeletal 
muscle angiogenesis in response to exercise (see reviews by (Hudlicka et al., 1992; Prior et al., 
2004; Bloor, 2005; Egginton, 2009)).   
Angiogenesis is a complex process thought to be regulated by a balance of pro-
angiogenic and anti-angiogenic factors. Among the pro-angiogenic factors known to regulate 
skeletal muscle angiogenesis, are vascular endothelial growth factor (VEGF) and matrix 
metalloproteinases -2 and -9 (MMP-2, MMP-9), which have all been shown to be essential in 
the angiogenic response to physical activity. For example, VEGF receptor antagonism partially 
inhibits training induced skeletal muscle angiogenesis in ischemic hindlimb muscles of mice 
(Lloyd et al., 2005) and sequestering circulating VEGF (using VEGF Trap) prevents increases in 
skeletal muscle angiogenesis induced by elevated shear stress or muscle stretch/overload 
conditions (Williams et al., 2006). We have recently shown that skeletal muscle angioadaptation 
to 6-weeks of high intensity treadmill training is absent in healthy myocyte VEGF-deficient mice 
(Olfert et al., 2010), demonstrating that myocyte-derived VEGF is required for exercise-induced 
skeletal muscle angiogenesis. Likewise, there is evidence that MMP’s are equally important and 
necessary for exercise-induced angioadaptation. Haas et al. (2000) have shown that 
pharmacological inhibition of MMP activity prevents capillary adaptation in chronic electrically 
stimulated hindlimb muscles, establishing that MMP activity is also required for skeletal muscle 
to undergo capillarity adaptation in response to chronic muscle contractions. Collectively these 
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studies highlight the importance of VEGF and MMP activity in the regulation of training-induced 
skeletal muscle capillary adaptation.  
Recently, anti-angiogenic factors have also been shown to be stimulated by exercise. 
For example endostatin and thrombospondin-1 (TSP-1) are increased in response to acute 
exercise (Gu et al., 2004; Olfert et al., 2006). Mice lacking TSP-1 also display a greater basal 
muscle capillarity and increase exercise performance compared to wild-type mice (Malek & 
Olfert, 2009).  Circulating endostatin has been shown to increase with acute exercise (Gu et al., 
2004), but is reduced after prolonged training in humans (Brixius et al., 2008; Suhr et al., 2010).  
Recent evidence suggests that the anti-angiogenic action of endostatin on endothelial cell 
activity may be dependent on the nuclear protein nucleolin (Shi et al., 2007).  Nucleolin has 
been previously used as a marker of endothelial cell proliferation for cells undergoing 
angiogenesis in tumors (Christian et al., 2003), but to our knowledge there are no published 
data on the effects of exercise on nucleolin expression.  Given that nucleolin is involved in 
transcription processing, editing and assembly of ribosomes and import/export of proteins from 
the cytoplasm to the nucleus (Srivastava & Pollard, 1999), it is conceivable that it may be 
altered or be responsive to exercise. Supporting this this idea, is circumstantial evidence that 
nucleolin may interact with angiogenic mitogens, such as VEGF (Huang et al., 2006),  bind to 
the 3’ region of MMP-9 stabilizing it for translation (Fahling et al., 2005), and interact with 
endostatin when translocated to the cell surface (Shi et al., 2007).  Thus, we have also sought 
to examine whether or not acute and/or chronic exercise might alter nucleolin expression. 
Several studies have reported the temporal transcriptional/gene expression responses of 
VEGF and MMPs (as well as other angiogenic mitogens) to acute and chronic exercise (Breen 
et al., 1996; Brown & Hudlicka, 2003; Lloyd et al., 2003; Gustafsson et al., 2005), but few 
studies have done so at the translational (i.e. protein) level. Understanding protein level 
changes in response to acute and chronic exercise is vitally important since it is known that 
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transcriptionally-mediated events do not always translate to protein biosynthesis. Moreover, 
factors like endostatin are not gene encoded peptides, but rather formed as a cleavage 
fragment from other molecules (e.g. endostatin is a 22-kd C-terminal fragment formed from 
collagen XVIII). Therefore, any response from endostatin to exercise, or in response to any 
stimulus, would not be detectable at the transcriptional level. Additionally, given the growing 
number of factors thought to regulate angiogenesis it is unlikely that the temporal protein 
responses to an angiogenic stimulus (such as exercise) would occur at one time point. Given 
the coordination of factors and events needed for successful control of angiogenesis, we sought 
to examine the temporal protein expression of several key angiogenic regulators (VEGF, MMP-
2, MMP-9, and nucleolin) in response to acute exercise, as well as at varying time points 
following chronic exercise training. We include the anti-angiogenic regulators (TSP-1 and 
endostatin) in conjunction with morphological assessment of skeletal muscle capillarity, to better 
understand the dynamic balance between several key positive and negative angiogenic 
regulators that are believed to significantly influence skeletal muscle angiogenesis. Specifically, 
we are testing the hypothesis that negative angiogenic regulators (such as endostatin and TSP-
1) are differentially expressed in response to acute versus chronic exercise, such that the 
actions of positive angiogenic molecules (VEGF, MMPs, and possibly nucleolin) are inhibited 
with acute, but not chronic, exercise.  
 
Materials and Methods 
Mice: All mice were purchased from Jackson Laboratories (Bar Harbor, ME) and housed 
in a pathogen-free vivarium room with 12hr:12hr light:dark cycle. Mice were fed rodent chow 
(Harlan Tekland 8604, Madison, WI) and tap water ad libitum. Animal care and handling were 
performed in accordance to PHS Animal Welfare Act and received approval by the West 
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Virginia University and University of California-San Diego Institutional Animal Care and Use 
Committees.   
Study 1 - Time course response to single bout of acute exercise: Twenty-four male 
C57Bl/6 mice were randomly assigned to either a control group (no exercise, n=4) or one of 
seven acutely exercised groups (n=4/group).  Following the 1-hour of acute exercise at 20 
m/min, 10° incline on a rodent treadmill (model CL-4, Omnitech, Columbus, OH), hindlimb 
gastrocnemius muscle was removed at either 0 (immediately post exercise), 2, 4, 6, 12, or 24 
hours post exercise from deeply anesthetized mice (details for tissue harvesting are provided 
below).  
Study 2 – Temporal response of angiogenic regulators to exercise training: Seventy-two 
male C57Bl/6 mice were randomly assigned into a control (no training, n=12) or one of five 
training groups (n=12/group). Training mice had free access to cage running wheels (4.5” 
Mouse Wheel, Respironics, Bend, OR) for either 3, 5, 7, 14, or 28 days. During wheel training 
mice were individually housed and wheel activity (i.e. distance, running time, mean running 
velocity, and maximum running velocity) was monitored and recorded every 24 hours using 
digital bike computers (Cateye Strada CC-RD100N, CatEye North America, Boulder, CO).    
Following training, wheels were removed from the cage, and mice were given a 24-hour 
exercise washout period prior to assessment of either basal or acute exercise responses. After 
the 24-hour exercise washout, half of the mice in each group were randomly selected to perform 
a 1-hour treadmill acute exercise (n=6) while the remaining mice served as basal controls (n=6). 
This allowed for examination of the responsiveness of angiogenic proteins to exercise following 
different days of training. For mice acutely exercised, the gastrocnemius muscle was surgically 
removed 4 hours after the acute exercise bout (1-hour at 20 m/min, 10 degree incline). The 4-
hour time point was selected based on the peak responses observed from Study 1. For all mice, 
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muscles from the left leg were used for molecular analysis and muscles from the right leg were 
used for morphometric analysis. 
Tissue collection and processing: All mice were anesthetized with sodium pentobarbital 
(Nembutal, 50 mg/kg) via intraperitoneal injection. Once anesthetized the gastrocnemius muscle 
from the left leg was carefully removed at its respective origin and insertion attachment, 
weighed, and immediately flash frozen in liquid nitrogen for protein analyses. The 
gastrocnemius from the right leg was removed in the same manner, positioned transversely on 
a cork base, carefully embedded in tissue freezing medium (TBS Tissue Freezing MediumTM, 
Triangle Biomedical Sciences, Durham, NC, USA) and immediately flash-frozen in liquid 
nitrogen cooled isopentane (2-methylbutane, Fisher Chemical O3551-4, Fisher Scientific). All 
muscle samples were stored at -80° C until processed for molecular or morphometric analyses. 
 Protein analysis: Skeletal muscle was homogenized using a lysis buffer containing 50 
mM Tris/HCl (pH 7.4), 150 mM NaCl, 0.5% Triton X-100, and protease inhibitors (Complete™ 
Tablet, Roche Applied Science, Indianapolis, IN). Homogenates were centrifuged at 4°C, 8000g 
for 10 minutes and supernatants removed and placed in new tubes. Total protein was measured 
by the bicinchoninic acid method (BCA protein assay kit, Bio-Rad Laboratories, Hercules, CA). 
Mouse VEGF, MMP-2, and MMP-9 protein levels were measured from 150 µg of total 
protein using a commercially available ELISA kits (VEGF #MMV00; MMP-2 #DMP2F0; MMP-9 
#MMPT90; from R&D Systems, Minneapolis, MN). All analyses were performed according to 
the manufacturer's specification and optical density was measured using a microplate reader at 
450 nm corrected by readings at 540 nm (Bio Rad Model 550, Global Medical Instrumentation 
Inc., Ramsey, Minnesota). TSP-1, endostatin and nucleolin were analyzed using Western 
Blotting. Muscle samples were denatured (36μg GA) and separated on 26 well 8% Bis Tris Midi 
Gels (Novex WG1003BX10, Carlsbad, CA) and blotted onto a 0.45μm nitrocellulose membrane 
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(nitrocellulose membrane #88018, Thermo Scientific, Rockford, IL). The membrane was blocked 
with 5% fat-free milk in TBS and probed with respective antibodies TSP-1 (Thrombospondin-1, 
A6.1, sc-59887, Santa Cruz Biotechnology, Santa Cruz, CA); nucleolin (nucleolin antibody 
#A300-711A, Bethyl Laboratories, Montgomery, TX); and endostatin (anti-mouse endostatin 
antibody #AF570 R&D Systems, Minneapolis, MN).  The housekeeping genes β-tubulin (#4970 
Cell Signaling Technology) and  GAPDH (mouse anti-GAPDH #39-8600, Invitrogen, Camarillo, 
CA) were used to normalize the respective levels of TSP-1, endostatin, and nucleolin measured 
in order to account for potential variations in total protein loaded within each gel. 
Chemiluminescence detection allowed for visualization of proteins (Pierce ECL Western Blotting 
Substrate, #32209, Rockford, IL), images of blots were taken using Genesnap software (version 
7.01; Syngene). Protein expression was quantified by using NIH ImageJ Software (version 1.62) 
and expressed as densitometric arbitrary units (A.U.).  The same control samples were always 
loaded on every gel in order to allow normalization of densitometry across blots and allow all 
groups to be compared relative to each other. 
Histochemistry. Frozen muscles embedded in tissue freezing medium were cut into 
serial 10 μm transverse sections using a cyrotome at -20°C (Reichert Jung Cryocut 1800; 
Cambridge Instruments, Buffalo, NY) and mounted on glass slides (Fisher Superfrost #12-544-
7, Fisher Scientific) for histochemical analysis of muscle morphometry. Great care was taken to 
ensure that the widest part of the muscle was sectioned and that cuts were made perpendicular 
to the orientation of the fibers. Muscle capillarity was determined by measuring capillary-to-fiber 
ratio (C:F) from alkaline phosphatase and dipeptidylpeptidase IV stained sections (Mrazkova et 
al., 1986). Stained muscle sections were viewed by light microscopy and digitally imaged at 25x 
magnification by a researcher blinded to the experimental group identity.  Muscle capillarity was 
assessed from deep and superficial regions in both lateral and medial gastrocnemius. Images 
were obtained in a non-overlapping checkerboard manner within each of the 4 quadrants (i.e. 
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lateral head superficial, medial head superficial, lateral head deep, medial head deep).  This 
resulted in an average of 771 ± 123 (SD) muscle fibers being analyzed from each animal.  
 Statistical Analyses: All data shown are mean ± SEM, unless otherwise indicated.  
Changes in protein expression, exercise performance during training (i.e. daily distance run, 
time running, average speed and maximal speed), and muscle capillarity (i.e. C:F) were 
analyzed using ANOVA. The combined effects of training (i.e. groups trained for different days) 
and the angiogenic factor response to acute exercise (i.e. basal vs. acute exercise) for proteins 
were separately determined using a 2 × 2 factorial ANOVA. When a main effect was observed, 
post hoc testing with a Fisher’s PLSD was used to examine group differences. All statistics were 
performed using Statview Statistical Software package (v5.0.01, SAS Institute Inc., Cary, NC). 
Significance was set at α level of p=0.05.  
 
Results 
Study 1 – Time course response to single bout of acute exercise.  Age, body and 
muscle masses of mice were not different in any of the respective groups for these mice (Table 
1). Expression of skeletal muscle VEGF, endostatin and nucleolin protein levels were 
significantly greater than control at 2 and 4 hours post exercise (p<0.05, Fig. 1).  MMP-2 tended 
to increase at 6 hour (p=0.057) and was significantly elevated at 12 and 24 hours post exercise 
(p<0.05, Fig. 1).  Neither, MMP-9 nor TSP-1 were significantly elevated at any time point up to 
24 hours post exercise (Fig. 1). 
 Study 2 – Temporal response of angiogenic regulators to exercise training.  Age was 
not different between the respective training groups.  Body mass after training was 
approximately 5% greater in the 3-day trained group (p=0.04) compared to control mice, but not 
different in 5- and 7-day trained groups (Table 2).  In contrast, body mass was 6% and 7% lower 
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in 14- and 28-day trained mice, respectively (p<0.01), compared to similar aged untrained 
control mice (Table 2).  The absolute gastrocnemius muscle mass, as well as relative muscle 
mass normalized to total body mass (i.e. GA/BM), were not different among any of the groups. 
The same was observed for the plantaris (PLT) and soleus (SOL) muscles, with one exception, 
where SOL/BM tended to be greater (p=0.04) in 28-day trained mice compared to controls 
(Table 2). 
Training performance and muscle capillarity. Voluntary wheel running behavior was 
similar when comparing performance measures (i.e. average daily running speed, daily maximal 
running speed, and time spent running each day) on the same relative day of training, indicating 
similar training behavior and pattern between groups (data not shown). However, as would be 
expected, measures of exercise performance (i.e. average running speed and greater distance 
run each day) increased with increasing exposure to training (Table 3). Although time spent 
running also decreased with increasing days training (p<0.05), the concommitant increased 
average running speed resulted in an overall effect of an increase in the average distance run 
each day. Maximal running speed performed during daily voluntary wheel training was not 
different between any of the trained groups (Table 3).  
Training increased capillary-to-fiber ratio (C:F) in the gastrocnemius muscle of mice 
beginning with 7-days of training, and increased further with 14- and 28-days of voluntary wheel 
training (p<0.01, at all time points) (Fig. 2). 
Basal muscle protein expression following training. Shown in Figure 3, VEGF (p=0.02) 
and MMP-2 (p=0.03) were significantly lower after 3 days of training compared to the control 
group. After 5 days of training, nucleolin (p=0.03) was elevated and MMP-9 (p=0.01) was 
reduced compared to the control group. The reduction in MMP-9 persisted with 7 and 14 days 
training (p<0.01). MMP-2 was also elevated with 5 days training compared to 3 day trained 
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levels, which also persisted with 7 and 14 days of training. In addition to altered MMP-2 and 
MMP-9 at 7 days of training, basal VEGF protein levels increased (p=0.03). Following 14 days 
of training, VEGF levels were not different than basal control levels, but was significanly lower 
after 28 days of training (p<0.01).  TSP-1 in 14d and 28d trained mice was significantly greater 
compared to 5d and 7d trained mice (p<0.05), but only tended to increase compared to basal 
control levels (p<0.10). 
Acute response to exercise following training. Following training, the angiogenic 
response to a single 1-hour exercise bout (treadmill running at 20 m/min, 10° incline) was 
assessed at the 4-hour time point following the exercise bout. It is notable, of three angiogenic 
regulators found to respond to acute exercise in the (untrained) control mice (i.e. VEGF, 
endostatin, and nucleolin), none were seen to be responsive to acute exercise after 7-days of 
training (Fig. 3) when C:F was significantly increased (Fig. 2). But, the VEGF response to acute 
exercise was present with 3- and 5-days of training.  Given that muscles were harvested at 4-
hours post exercise in each of the trained groups, the responses of angiogenic regulators (e.g. 
MMP-2, MMP-9 and TSP-1) whose peak responses occurred either before or after this time 
point would have limited, if any, interpretative value.   
 
Discussion 
The principal finding of this study is that the expression of key angioregulatory proteins 
are markedly up-regulated in either early (2-4 hours) or late phase (12-24 hours) post acute 
exercise. We find that VEGF, endostatin, and nucleolin protein levels were elevated in the early 
phase, whereas other regulators (such as MMP-2, and to lesser extent TSP-1) responded much 
later post exercise, showing that exercise elicits a complex but coordinated process involving 
positive and negative regulators. The new observation that nucleolin was increased with acute 
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exercise is particularly interesting since it may interact and influence several key angiogenic 
mitogens (i.e. VEGF, MMP-9 and endostatin). Our data also provide evidence that chronic 
exercise training alters the responsiveness of VEGF to exercise after capillary adaptation has 
taken place. Collectively, these data provide evidence supporting the idea that exercise-induced 
skeletal muscle angiogenesis is a multifaceted processes involving positive and negative 
regulators and whose responses are temporally coordinated to limit or prevent angiogenesis in 
response to acute exercise, but which are differentially altered by chronic exercise in manner 
that allows or faciliates capillary expansion.  
 
Temporal responses to single bout of acute exercise 
The skeletal muscle VEGF mRNA response to exercise has been well characterized 
with peak responses occuring between 1-2 hours and returning to baseline levels by 4-8 hours 
(Breen et al., 1996; Gustafsson et al., 2005). Our data show that peak VEGF protein expression 
in mice occurs between 2-4 hours following a single bout of exercise, which is consistent with a 
transcriptionally-mediated event that contributes to the rise of VEGF protein expression (Tang et 
al., 2002).  Nonetheless, we cannot exclude the possibility that exercise-induced post-
translational modifications may have also contributed to the rise in VEGF protein. The observed 
temporal response in this study, is also consistent with a previous report in rats showing 
significantly elevated VEGF protein 4-hours post exercise in the soleus and plantaris muscles 
(Malek et al., 2010).  In contrast, VEGF protein levels measured from muscle biopsy in human 
vastus lateralis muscle have been reported to be lower immediately following exercise and 
return to baseline levels by 4 hours post exercise (Gavin et al., 2004).  Likewise, another study 
reports no VEGF mRNA or protein response to acute exercise in young and old adults 4-hours 
after exercise (Ryan et al., 2006).  While there are several studies that show a significant VEGF 
29 
 
mRNA response to acute exercise in healthy adults (Gustafsson et al., 1999; Richardson et al., 
1999; Gustafsson & Sundberg, 2000; Richardson et al., 2000), none that have analyzed muscle 
biopsies have found elevated muscle VEGF protein between 0-6 hours post exercise. Thus, 
although the temporal response of exercise at the transcriptional (mRNA) level may be similar 
between rodents and humans, translation at the protein level appear to have very different 
temporal responses. At present there is not a clear explanation for this discrepancy at the 
protein level between rodents and humans, but one concern may be that the relatively small 
amount of muscle tissue that can feasibly be obtained from a human muscle biopsy may not 
fully represent the proteomic response occurring within the whole muscle. 
Similar to VEGF, we observed that endostatin was significantly elevated in the 
gastrocnemius at 2- and 4-hours post exercise. Our data are consistent with the observation 
that circulating endostatin levels are elevated following acute exercise in humans (Gu et al., 
2004; Rullman et al., 2007; Suhr et al., 2007). This response may seem counter intuitive, but it 
has been previously shown that acute exercise increases gene expression of other negative 
angiogenic regulators, such as TSP-1 (Olfert et al., 2006). The prevailing concept is that up 
regulation of both positive and negative angiogenic regulators occurs in response to a single 
acute exercise bout to limit and/or prevent unnecessary utilization of energy and biological 
resources for capillary expansion in response to a single, one-time, stimulus. And that, capillary 
expansion only occurs in response to reoccurring or repeated exercise-induced mechanical or 
metabolic stress (Egginton, 2009; Olfert & Birot, 2011).  The response observed for endostatin 
in this study adds credence to this idea. With this in mind, we were surprised to observe no 
significant increase in muscle TSP-1 protein expression, particularly given the recent evidence 
supporting a role for TSP-1 as a key negative angiogenic regulator in skeletal muscle (Olfert et 
al., 2006; Malek & Olfert, 2009; Roudier et al., 2010; Hoier et al., 2012). It is, however, 
interesting to note that there was a trend for TSP-1 protein levels to increase at 12-24 hours 
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post exercise (p=0.09).  Therefore, it may be that the peak TSP-1 response occurs beyond 24 
hours, which was not measured in our study.  Another recent study also found no change in 
TSP-1 protein levels in mice 4 hours following acute exercise (Audet et al., 2011), but in light of 
the present data this is not surprising. Based on these data, it might be interpreted that TSP-1 is 
unimportant in regulating exercise-induced skeletal muscle angiogenesis. But, given the robust 
TSP-1 mRNA response to exercise in rodents (Olfert et al., 2006; Kivela et al., 2008) and 
humans (Hoier et al., 2012; Hoier et al., 2013), it may be premature to rule out the involvement 
of TSP-1. Further studies examining and documenting the TSP-1 protein responses to exercise 
are needed, before we may fully appreciate its contribution. 
 We also report the expression of nucleolin, which has been used as a marker of 
endothelial cell undergoing angiogenesis (Christian et al., 2003), and whose activity has been 
linked to endostatin (Shi et al., 2007), as well as interacting with VEGF and MMP-9 (Fahling et 
al., 2005; Huang et al., 2006). Given the increase in nucleolin at 2 and 4 hours post exercise, at 
a time point similar to the time profile seen with VEGF and endostatin, it is tempting to speculate 
that VEGF (in response to exercise) may help to facilitate translocation of nucleolin from the cell 
nucleus to the cell surface of proliferating endothelial cells (Christian et al., 2003; Huang et al., 
2006).  And, if nucleolin serves as a binding partner for endostatin to be internalized on 
proliferating endothelial cells (Shi et al., 2007; Song et al., 2012), this would provide an effective 
means for feedback regulation that could limit and/or brake the angiogenic response of VEGF to 
an acute exercise stimulus. To our knowledge, no previous studies have investigated nucleolin 
in skeletal muscle in response to exercise, but based on this evidence we believe further 
investigation into nucleolin and its potential interaction with VEGF and endostatin are warranted.   
 The importance of MMPs, particularly MMP-9 and MMP-2, have been recognized in the 
context of muscle angioadaptation  (Haas et al., 2000; Rivilis et al., 2002; Brown & Hudlicka, 
2003; Milkiewicz & Haas, 2005), but the temporal responses to acute exercise are still poorly 
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defined. We found no significance increase in MMP-9 protein in response to acute exericse in 
our mice, but did observed a significant elevation during the late phase (12-24 hours) after 
exercsie. A recent report using the vastus lateralis muscle of exercising humans has reported 
no increase in MMP-2 protein following acute exercise (Rullman et al., 2007), but based on our 
data this is perhaps not surprising since those data were obtained 2-hours post exercise. Other 
studies have reported increases in circulating MMP-2 protein in humans 30-min after acute 
high-intensity exercise (Suhr et al., 2007) and up to 1-hour post exercise in endurance track 
athletes (Suhr et al., 2010). But it is presently not clear whether circulating levels of MMPs have 
a significant impact, or even a direct relationship, on skeletal muscle angiogenesis per se 
(Rullman et al., 2012).  For MMP-9, we saw no significant skeletal muscle MMP-9 protein 
response following acute exercise in mice. But, in humans, Rullman et al. (2007) have reported 
an increase in MMP-9 mRNA and total protein in human vastus lateralis muscle immediately 
after and 2-hours post acute exercise. Likewise, Suhr et al. (Suhr et al., 2007) report increased 
circulating MMP-9 from 1-4 hours after exercise in track athletes. While some of the conflicting 
outcomes reported in skeletal muscle may be attributable to the varying time points selected for 
analysis post exercise, it may also be (as that seen for VEGF) that rodents and humans exhibit 
different temporal responses for MMPs in response to exercise. We also cannot rule out the 
possibility that some of the conflicting results may be explained by differing exercise intensity 
performed between studies (discussed further in following section). 
 
Temporal effects of training on muscle capillarity 
Skeletal muscle capillary adaptation to training has been well studied since it was first 
reported by Vanotti & Magiday (1934); and as seen in Table 3, the voluntary wheel training 
paradigm we used resulted in significant increases in capillary-to-fiber ratio starting with 7-days 
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of training, and continued to increase with longer exposure (i.e. 14- or 28-days) to daily 
exercise.  While it was expected that animals with longer exposure to training would exhibit 
better exercise performance attributes (such as the ability to run longer and/or run at a faster 
average speed) compared to those with fewer training days (Table 3), it is important to note that 
we monitored daily training behaivor in all groups and found no difference in the daily absolute 
performance measures of mice across the training groups when compared at the same relative 
day in the training paradigm (i.e. comparing running metrics in all groups at 3-day, or at 5-day, 
etc). This means the responses between the trained groups we observed in our study are not 
likely due to differences in volunatry training behavior, but rather most likely to the level of 
physiological adaptations that occurred with training (e.g. level of muscle capillarity). Given the 
plieotrophic effects of whole body exercise, we cannot directly point to any single training-
induced physiological adaptations (such as increased muscle capillarity) as being solely 
responsible for altering the responses we observed, but it is reasonable to interpret the 
individual and collective outcome of these angiogenic regulators with respect to their putative 
affect on angiogenesis.   
 
Basal response of angiogenic regulators following exercise training 
Basal expression of VEGF protein was lower in 3- and 28-day trained mice, but elevated 
at 7-days training, compared to (untrained) controls. The lower basal VEGF protein levels after 
3-days of training was surprising, and directly contrasts to a previous report in the plantaris 
muscle of healthy mice (Waters et al., 2004).  The reason for this discrepancy is not clear, but 
the rise in basal VEGF after 7-days of training, which coincides with elevated muscle capillarity 
(seen in Fig. 2) is consistent with the existing data (Waters et al., 2004), and suggests a basal 
condition that is favorable for angiogenesis. Surprisingly, we observed that basal VEGF levels 
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fell in 28-day trained mice compared to basal untrained levels. This might suggest a feedback 
mechanism designed to limit or slow down capillary expansion once a sufficient level of 
angiogenesis has taken place. The observation of normalized muscle basal VEGF protein 
expression following training, after capillary expansion has occurred, has also been observed in 
humans following training (Hoier et al., 2012). Taken together, our temporal analysis of basal 
VEGF in association with training-induced muscle capillary adaptation provide evidence of a 
complex control of VEGF, and suggest that basal level expression may be linked to the degree 
of capillary adaptation. This idea is supported by microarray analysis indicating that the genomic 
responses to aerobic exercise in human skeletal muscle is influenced by the magnitude of 
physiological adaptation which has occurred (Timmons et al., 2005), which emphasizes that 
comparing and contrasting VEGF responses (or perhaps of any angioregulatory factor) to 
training among different studies may be difficult to interpret unless the level of capillary 
adaptation is also known and reported. 
With respect to TSP-1, we found that basal protein levels of this anti-angiogenic factor 
were decreased with 5- and 7-days training compared to 14- and 28-days (Fig. 3), suggesting 
that longer exposure to training may act to slow the capillary expansion by elevating basal TSP-
1 levels. This is consistent with the notion that a balance between positive and negative 
angiogenic regulators control skeletal muscle angiogenesis, and is supported by our data 
showing reduced basal VEGF, but elevated basal TSP-1, in 28-day trained mice. This is also 
consistent with mRNA expression profile which have been reported separately for TSP-1 (Olfert 
et al., 2006) and VEGF (Gavin & Wagner, 2001) with short-term training (up to 5-days) in the 
skeletal muscle of rats.  In contrast, however, Hoier et al. have recently shown unaltered basal 
TSP-1 and VEGF proteins following 4-weeks of bicycle ergometer training that resulted in an 
increase of muscle C:F (Hoier et al., 2012). There could be several explanations for the 
apparent difference. First, as we have previously noted with respect to acute exercise 
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responses, there could simply be differences in the temporal response of humans and rodents 
to exercise. Another potential explanation may be that myocytes are not the source of TSP-1. 
Indeed, TSP-1 is an extracellular matrix protein that is produced by a wide variety of cells, such 
as platelets, fibroblasts, macrophages, and other cells (Bornstein, 1992); thus exercise-induced 
alterations in TSP-1 could originate from non-myocyte sources.  Supporting this, Hoier et al. 
(2013) have recently shown decreased TSP-1 protein in extracellular muscle dialysate fluid 
(obtained from indwelling muscle catheters) after 4-weeks moderate-to-high-intensity training in 
man. On the other hand, in the same report, Hoier et al. (2013) show increased TSP-1 protein in 
muscle dialysate following high-intensity intermittent exercise in the same subjects, emphasizing 
that exercise intensity (and subsequent physiological adaptation) likely exerts an important 
influence on the angioregulatory protein response of skeletal muscle to training. Thus, it may be 
difficult to compare training responses unless the exercise intensity is similar, and that it may be 
even more difficult to compare across species (as we have previously seen for VEGF between 
rodents and humans). 
There are a limited number of studies examining the involvement of endostatin in 
exercise-induced skeletal muscle angiogenesis. While circulating endostatin levels under basal 
conditions have been shown to be reduced after six months of training in untrained men and 
short-/long-track athletes (Brixius et al., 2008; Suhr et al., 2010), our data examining basal 
muscle expression of endostatin do not show this in mice. Based on the human data, it could be 
that we needed a longer training period to get a reduction in endostatin, but given the significant 
rise in muscle capillarity observed after 28-days of training it would appear that a reduction in 
basal endostatin was not needed for capillary expansion to occur. However, based on the acute 
protein response we, and others, have observed for endostatin, it appears that endostatin may 
be one of several potential negative regulators that serve to prevent or limit angiogenesis in 
response to acute exercise. 
35 
 
As seen with endostatin, no significant changes in basal protein expression of nucleolin 
were observed with training. If the role of nucleolin involves interaction with endostatin in 
response to acute exercise, then this is perhaps not surprising. However, before the importance 
of nucleolin can be determined in response to acute exercise or training, additional studies 
examining the effect of exercise on the translocation of nucleolin to the endothelial cell surface, 
and to what extent VEGF and endostatin are dependent on nucleolin are needed. 
Because previous reports show increased skeletal muscle MMP mRNA and protein in 
response to electrically-stimulated contractions and/or prazosin-mediated increases in vessel 
shear stress (Haas et al., 2000; Rivilis et al., 2002; Brown & Hudlicka, 2003), we were surprised 
to observe that basal MMP-2, and to a larger extent MMP-9, protein expression were 
significantly lower with training in our mice (Fig. 3).  Our data are in stark contrast to existing 
studies, most of which show elevated MMP levels following various intensity and length of 
training in rats (Haas et al., 2000; Carmeli et al., 2007) and humans (Rullman et al., 2009).  For 
example, single-leg training in humans for only 10 days is reported to increase both MMP-2 and 
MMP-9 mRNA and total protein activity in the exercising muscle (Rullman et al., 2009). An 
explanation for the discrepancies between our data and those previously published may be due 
to training paradigm (i.e. voluntary wheel running) we used.  Using a rat model, Carmeli et al. 
(2005) have reported that MMP-2 response to training is exercise intensity dependent, such that 
high intensity training (~70% of maximal oxygen consumption, VO2max) was needed to 
increase MMP-2 expression in the gastrocnemius muscle of rats, whereas training at ~50% of 
VO2max was not sufficient (Carmeli et al., 2005). Despite the high daily volume of training 
voluntarily performed by our mice (up to 6 km per day), the average running speed during 
training ranged between 12 to 18 m/min (0.71 - 1.06 km/hr, Table 3).  If one accepts the 
maximal treadmill running speed for C57Bl/6 mice is between 35-45 m/min (Høydal et al., 2007; 
Malek & Olfert, 2009; Olfert et al., 2009), the average running speed during voluntary wheel 
36 
 
training performed by our mice would only be approximately 34-40% of their maximum exercise 
capacity. Thus it may be that we do not find significant increases in MMP due to the low-
intensity training that was voluntarily performed by our mice. Nonetheless, it should be noted 
that we did find that 5-, 7- and 14-days of training resulted in significant increase in total basal 
MMP-2 protein compared to that seen with 3-days training (Fig. 3), and that a similar trend 
existed for elevated basal MMP-2 with 7 days training compared to basal levels in control mice 
(p=0.07, Fig. 3). Thus, exercise intensity may play an important role in MMP response to 
exercise training. This could, in part, also explain the discrepancies in our acute exercise data 
(showing a non-significant response, Fig. 1) compared to the increase in MMP-9 protein seen in 
humans immediately and 2-hours after a single acute bout of exercise (Rullman et al., 2012). 
We estimate the relative intensity of the single 1-hour exercise bout (at 20 m/min with 10-degree 
incline) performed by our untrained mice is about 50-60% of the maximal capacity in these 
mice.  Therefore, even though it appears there was a tendency for MMP-9 to be elevated at 0- 
and 2-hours post acute exercise (compared to controls) (Fig. 1), the exercise intensity 
performed for acute exercise might explain why a greater response was not observed. 
 
Acute exercise responses of angiogenic regulators following exercise training 
To examine that acute responsiveness of these angioregulatory proteins in trained mice, 
we subjected mice in each of the trained groups to a 1-hour standardized treadmill exercsie 
bout (i.e. 20 m/min, 10-degree incline) after a 24-hour window of time following the removal of 
the running wheel from the animals cage. We selected the 4-hour time-point post exercise to 
assess the responsivness to acute exercise, because it corresponded to the most significant 
time point we initially observed in the untrained mice (Study 1, Fig. 1).  Accordingly, it must be 
recognized that we are only able to interpret the outcomes to acute exercise for VEGF, 
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endostatin, and nucleolin, because the responses for these factors occurred at this time point. 
Nevertheless, due to scarcity of data and an expanding need to document the molecular 
interplay that occurs in trained versus sedentary conditions, we have still reported (in Fig. 3) the 
outcome for acute exercise for all the factors we evaluated, even though the interpretative value 
of TSP-1, MMP-2 and MMP-9 (which were found not to respond at 4 hours) are likely to be less 
informative. As such, we have limited our discussion here to focus only on those factors which 
were significant 4-hours post acute exercise (i.e. VEGF, endostatin and nucleolin). 
As reported in previous studies, skeletal muscle VEGF protein was significantly 
increased in response to acute exercise in untrained subjects (Malek et al., 2010; Hoier et al., 
2012).  Our study reveals that the VEGF response is lost after 7-days of training, and remains 
attenuated following 14- and 28-days of training in mice (Fig. 3).  The fact that these time points 
correspond temporally to a significant increase in muscle capillarity (Fig. 2) would suggest that 
elevated muscle capillarity (and/or other training related adaptations) have likely reduced or 
lessened metabolic stress (e.g. shear stress, local tissue hypoxia, stretch, etc) associated with 
exercise, and therefore reduced the underlying stimulus for activating VEGF. This idea is 
supported by previous data showing that in rats trained in hypoxia (which resulted in increased 
muscle capillarization) the VEGF mRNA response to exercise was blunted, whereas rats trained 
at the same absolute training intensity in normoxia (which did not increase muscle capillary, 
presumably due to the significantly lower relative training intensity they experienced) exhibited a 
similar VEGF mRNA response to acute exercise as that seen in untrained rats (Olfert et al., 
2001).  Likewise, neither endostatin nor nucleolin were found to exhibit a significant response to 
acute exercise following training (Fig. 3).  Given the basal levels of endostatin and nucleolin are 
unchanged with training, the most likely interpretation of these data are the that endostatin and 
nucleolin only play a significant role in regulating the initial muscle response to exercise by 
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limiting and/or preventing angiogenesis in response to acute exercise, and not in response to 
chronic exercise training. 
 
In conclusion, the principal finding of this study is that angiognesis resulting from 
exercise training is dependent on coordination of both positive (VEGF, MMP-2, nucleolin) and 
negative (TSP-1, endostatin) angiogenic regulators. In response to acute exercise there 
appears to be early (2-4 hours) and late (12-24 hours) phase protein responses, whereas with 
training these responses are attenuated or lost. To our knowledge, we believe these are the first 
data to suggest that nucleolin may serve (in concert with VEGF and endostatin) as an important 
peptide in response to acute exercise, such that endostatin may serve to inhibit the initial 
angiogenic response to acute exercise by countering the actions of VEGF via a nucleolin-
mediated mechanism. These data also highlight that the temporal responses we observed in 
mice, particularly for VEGF, MMP-2 and MMP-9, may not be directly comparable to humans. 
Nonetheless, when taken together, our results show that there is a complex coordination in the 
protein responses of both positive and negative angiogenic factors that correspond with training-
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TABLES AND FIGURES 
 
Group Age (days) Body Mass (g) GA (mg) PLT (mg) SOL (mg) HRT (mg) 
Controls 72±0 25.7 ± 0.7 137.0 ± 3.2 20.3 ± 0.9 6.4 ± 0.4 132.7 ± 3.6 
0 Hours 71±0 26.5 ± 0.3 146.9 ± 2.7 19.1 ± 0.4 7.4 ± 0.5 117.9 ± 4.8 
2 Hours 72±0 26.6 ± 0.3 139.0 ± 4.5 21.2 ± 1.0 8.2 ± 0.3* 133.4 ± 4.2 
4 Hours 71±0 23.6 ± 0.7 127.4 ± 4.8 18.2 ± 1.4 6.9 ± 0.3 130.3 ± 4.6 
6 Hours 72±0 24.4 ± 0.4 131.6 ± 4.4 18.8 ± 0.3 6.6 ± 0.3 123.5 ± 4.6 
12 Hours 71±0 25.3 ± 0.2 136.7 ± 2.6 21.1 ± 1.6 6.5 ± 0.4 117.6 ± 2.4 
24 Hours 72±0 25.2 ± 0.4 131.2 ± 1.0 19.2 ± 0.4 7.5 ± 0.2 128.4 ± 2.5 
 
Table 1. Mean±SE. Average age, body and muscle mass in mice sacrifice at the select times following a single acute exercise bout 
(n=4/group). GA=gastrocnemius, PLT=plantaris, SOL=soleus, HRT=heart. No significant differences are seen between mice in any 








 Age Body Mass (g) GA (mg) GA/BM (%) PLT (mg) PLT/BM (%) SOL (mg) SOL/BM (%) 
Control 74±1 25.0 ± 0.4 133 ± 4 0.53 ± 0.01 15.3 ± 0.7 0.061 ± 0.003 6.7 ± 0.2 0.027 ± 0.001 
3d 73±1 26.3 ± 0.4* 139 ± 2 0.53 ± 0.01 14.7 ± 0.6 0.056 ± 0.002 7.2 ± 0.4 0.027 ± 0.001 
5d 67±2 24.4 ± 0.5 130 ± 5 0.53 ± 0.01 13.8 ± 0.8 0.057 ± 0.004 7.2 ± 0.4 0.029 ± 0.002 
7d 73±3 25.1 ± 0.3 137 ± 3 0.55 ± 0.01 14.1 ± 1.0 0.056 ± 0.004 7.3 ± 0.3 0.029 ± 0.001 
14d 81±4 23.6 ± 0.4* 123 ± 4 0.52 ± 0.02 17.2 ± 1.2 0.073 ± 0.005 7.3 ± 0.7 0.031 ± 0.003 
28d 74±1 23.3 ± 0.5* 126 ± 7 0.54 ± 0.02 13.8 ± 0.5 0.059 ± 0.002 7.4 ± 0.3 0.032 ± 0.001* 
 
Table 2.  Mean±SE. Average age, body and muscle mass following voluntary wheel running training for 3, 5, 7, 14 or 28 (d)ays 














Table 3. Mean±SE. Characterization of voluntary running wheel training behavior following 3, 5, 
7, 14 or 28 (d)ays (n=12/group). Data represented are average data obtained from the last 24 
hours for each respective group, except for “Start of Training” which is the combined average for 














363 ± 21 0.71 ± 0.02 3.64 ± 0.20 2.59 ± 0.06 
3d 319 ± 27 0.75 ± 0.02 4.19 ± 0.39 2.63 ± 0.06 
5d 261 ± 13* 0.85 ± 0.04** 4.05 ± 0.34 2.64 ± 0.04 
7d 289 ± 29 0.93 ± 0.05** 4.89 ± 0.57* 2.54 ± 0.07 
14d 205 ± 15** 1.02 ± 0.04** 3.91 ± 0.38 2.67 ± 0.07 




Figure 1. Protein time course expression of VEGF, MMP-2, MMP-9, TSP-1 (165kDa), 
endostatin (22kDa) and nucleolin (100kDa) following single bout of acute exercise measured by 
ELISA or Western Blot analysis. Representative blots are shown. Control mice did not exercise, 
all others ran for 1 hour (at 20 m/min, 10° incline) and were sacrificed immediately (0), 2, 4, 6, 
12 or 24 hours post exercise (n=4 mice each group). A.U.= arbitary densitometry units 
respresenting Western blot analysis for which each respective factor has been normalized to the 
housekeeping gene GAPDH (40kDa) and/or β-tubulin (55kDa).  * Significantly different 
compared to Basal Control group, p<0.05; $ signifies p ≤0.10 compared to Basal control. 
Figure 2. Gastrocnemuis muscle capillary-to fiber ratio (C:F) in control, untrained, mice 
and in mice that voluntarily trained for 3, 5, 7, 14 or 28 (d)ays (n=6/group). ** p<0.01 compared 
to control. 
Figure 3. Time course protein expression of VEGF, MMP-2, MMP-9, nucleolin (100kDa), 
endostatin (22kDa) and TSP-1 (165kDa) following training measured by ELISA or Western Blot 
analysis. Representative blots are shown. Control mice are untrained, all others voluntarily 
trained using a running wheel for 3, 5, 7, 14, or 28 days (n=12/group). Following training, half of 
the mice per group (n=6) were elevated under basal conditions, and the other half (n=6) 
performed a single bout of exercise (1 hour, 20 m/min, 10° incline) with muscle harvested 4-
hours post exercise. A.U.= arbitary densitometry units respresenting Western blot analysis for 
which each respective factor has been normalized to the housekeeping gene GAPDH (40kDa). 
* significantly different compared to Basal Control group, p<0.05; ‡ significantly different 
between Basal and Acute exercise within same training group, p<0.05; † significantly different 
compared to 3 day trained Basal levels, p<0.05; # significantly different compared to 14-day 
trained Basal levels, p<0.05; $ signifies p ≤0.10 compared to Basal control.
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Temporal expression of positive and negative angiogenic factors in response to detraining is 
poorly understood.  We report the protein expression of anti-angiogenic peptides 
(thrombospondin-1, TSP-1; and endostatin) as well as pro-angiogenic mitogens (vascular 
endothelial growth factor, VEGF; matrix metalloproteinases-2 and MMP-9), and nucleolin (a 
nuclear protein involved with synthesis and maturation of ribosomes) in response to detraining 
in triceps surae muscles of mice. Mice were allowed to voluntarily train for 21 days, and then 
basal and acute response to exercise were evaluated at 1-, 7-, 14- and 28-days detraining (D1, 
D7, D14, D28 groups, respectively, n=12/group).  Training resulted in the expected increases 
muscle capillary-to-fiber ratio (C:F), maximal run test and basal expression of VEGF and MMP-9 
(p<0.05), as seen in the D1 group (i.e. trained control) mice. After 7 days of detraining (D7), C:F 
returned to control levels, but both basal VEGF and TSP-1 were elevated  (p<0.05). In D14 and 
D28 group mice, TSP-1 protein fell to baseline levels, but VEGF remained elevated in 
gastrocnemius, but not the soleus or plantaris, of D14 mice.  Endostatin tended to decrease with 
detraining, resulting in significantly lower basal levels by D14 and D28 for most muscles 
compared to controls. Nucleolin protein expression was inconsistent across muscle, with 
increases at D1 in the plantaris, D7 in the soleus and D14 in the gastrocnemius. The response 
of VEGF to acute exercise was blunted with training, and surprisingly was still blunted even after 
28 days of detraining, despite the return of muscle capillarization to baseline levels.  These data 
suggest that TSP-1 may be an important mediator in capillary regression with detraining.  The 
responses of VEGF and MMPs to detraining did not change in correlation to changes in muscle 
capillarity, suggesting that pro-angiogenic regulators may not play a prominent role in regulating 




Skeletal muscle has a tremendous plasticity to adapt in response to exercise.  One 
important adaptation is increasing capillarity in the working muscle to help reduce the metabolic 
stress imposed during physical activity (Andersen & Henriksson, 1977). While the molecular 
underpinnings of capillary expansion (i.e. angiogenesis) have been intensely studied, our 
understanding of the mechanisms involving physiologic mediated regression of muscle 
capillaries (i.e. physical deconditioning after cessation of training) is less well understood. 
It is generally accepted that exercise induced skeletal muscle angiogenesis is controlled 
by a balance between positive and negative factors (Egginton, 2009; Olfert & Birot, 2011). 
Among the angioregulatory factors believed to be important in skeletal muscle are: pro-
angiogenic vascular endothelial growth factor (VEGF), and anti-angiogenic thrombospondin-1 
(TSP-1), both of which have been shown to exhibit robust mRNA response to an acute bout of 
exercise in rodents and humans  (Breen et al., 1996; Gustafsson et al., 1999; Richardson et al., 
1999; Gavin & Wagner, 2001; Olfert et al., 2006; Hoier et al., 2012).  Gene deletion strategies in 
mice have shown that muscle-specific loss of VEGF decreases muscle capillarity (Tang et al., 
2004; Olfert et al., 2009), whereas a loss of TSP-1 increases basal muscle capillarity (Malek & 
Olfert, 2009).  Moreover, lack of skeletal muscle VEGF has been reported to prevent training 
induced skeletal muscle angiogenesis (Olfert et al., 2010), demonstrating the myocyte VEGF is 
essential to capillary expansion in response to physical exercise. But to what extent VEGF, 
TSP-1, and/or other key angiogenic regulators influence capillary regression upon cessation of 
training (i.e. detraining) is less well understood.  
Unlike tumor angiogenesis, which represents an uncontrolled and dysregulated 
expansion of blood vessels (Folkman, 1995; Hanahan & Folkman, 1996), physiologically-
mediated angiogenesis (such as that seen in the female reproductive cycle or response to 
exercise training) is a tightly-controlled, highly-coordinated multiple-step process regulating 
endothelial cell proliferation, extracellular matrix remodeling and vessel wall 
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assembly/stabilization (Iruela-Arispe et al., 1995; Prior et al., 2004).  It is conceivable that timing 
of pro- and anti-angiogenic regulator expression plays an important part in the successful 
execution of this highly choreographed process (Egginton, 2009; Olfert & Birot, 2011). Likewise, 
it could also be expected that the temporal expression of angiogenic regulating peptides may 
also determine the physiologic regression of skeletal muscle capillary in response to detraining.  
 At present, we are aware of only 2 studies that report the expression of VEGF following 
detraining in skeletal muscle. Malek et al. report that VEGF protein in the plantaris muscle has 
not returned to control levels after 7 days of detraining in previously trained rats (Malek et al., 
2010). And, Huttemann et al. (2012) report (in mice which trained for 5 weeks) that VEGF 
protein in the gastrocnemius muscle remained elevated after 14-days of detraining. They also 
report that TSP-1 was significantly decreased with training but returned to untrained control 
levels following 14-days of detraining (Huttemann et al., 2012), suggesting that altered 
expression of TSP-1 (and not VEGF per se) may be responsible for the detraining mediated 
losses in skeletal muscle capillarity.  Taken together, these 2 studies suggest the temporal 
response of VEGF and TSP-1 may differ with time spent detraining. But given that only one time 
point was assessed in either study, it is difficult to characterize and interpret any temporal 
effects. Moreover, neither study included assessment of other angiogenic regulators, such as 
matrix metalloproteinases (MMPs) or endostatin, which are also important in regulating 
angiogenesis. For example, MMP-2 and MMP-9 may be especially important because they are 
necessary to destabilize the basement membrane of the existing vasculature and the 
extracellular matrix (ECM) (Nagase & Woessner, 1999; Haas et al., 2000).  Endostatin, which is 
a 22-kD anti-angiogenic fragment of collagen XVIII  cleaved by MMPs, is capable of inhibiting 
VEGF and up regulating TSP-1 (Yamaguchi et al., 1999; Kim et al., 2000; Kim et al., 2002; 
Volpert et al., 2002; Hu et al., 2012) and therefore could have a significant influence on capillary 
regression.  At present, however, nothing is known about the expression of endostatin in the 
context of detraining. Also of interest, is the finding that endostatin activity may be dependent on 
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nucleolin -- a nuclear protein found on the surface of endothelial cells undergoing proliferation 
and which is also important for processing ribosome transcription, editing and assembly, and in 
the import/export of proteins to the nuclear membrane (Lapeyre et al., 1987; Srivastava & 
Pollard, 1999). Nucleolin and endostatin appear to co-localize on the cell surface, which can 
lead to endostatin transport to the nuclei (via nucleolin) where its inhibiting effects on cell 
proliferation can take place (Shi et al., 2007). Thus the temporal expression of nucleolin and 
endostatin could be an important pathway regulating the physiologic adaptation of microvessels 
within skeletal muscle.  
We hypothesize that detraining will preferentially increase the temporal expression of 
key negative angiogenic regulators (such as TSP-1, endostatin) with little influence on basal 
expression of pro-angiogenic regulators (such as VEGF, MMP-2, MMP-9, nucleolin), leading to 
regression of muscle capillaries and reduced exercise performance with detraining. To test this 
hypothesis, we provided mice with 24-hour access to running wheels for 21 days (a voluntary 
training paradigm known to significantly increase hindlimb skeletal muscle capillarity). Then 
muscle capillarity, as well as the basal and acute protein response to exercise, were separately 
examined after 1-, 7-, 14- and 28-days of detraining (D1, D7, D14 and D28, respectively).  
 
MATERIALS AND METHODS 
Mice: Male C57BL/6 mice were purchased from Jackson Laboratories (Stock# 000664, 
Bar Harbor, ME). Mice were housed in 12hr:12hr light:dark cycle with provided free access to 
food and tap  water. Experiments and animal care/handling were performed in accordance to 
PHS Animal Welfare Act and received approval by West Virginia University Institutional Animal 
Care and Use Committee. 
Training and Deconditioning: Sixty C57BL/6 mice were randomly assigned into a control 
group (no training) or one of four groups corresponding to 1-, 7-, 14- and 28-days detraining 
(n=12/group) after 21 days of training. For training, all mice (except control mice) were given 24-
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hour access to running wheels to voluntarily train for 21 days prior to detraining. Mice were 
individually housed in cages containing a running wheel (4.5” Mouse Wheel, Respironics, Bend, 
OR) connected to a bike computer (Cateye Strada CC-RD100N, CatEye North America, 
Boulder, CO) which digitally measured and recorded distance, running time, mean running 
speed, and maximum running speed. Performance over a 24-hour period was recorded each 
day for each animal. Upon completion of training the wheels were removed from the cages and 
mice were detrained according to the respective temporal assignment (i.e. D1, D7, D14 and 
D28).  Basal muscle expression for D1 (n=6) was evaluated after one full-day without access to 
the running wheel, and therefore essentially serves as a trained control group. The day without 
access to the running wheel was to minimize any acute response to wheel running exercise. 
The remaining detraining groups were sacrificed on the day indicated for each respective group 
(i.e. D7, D14, D28; n=6/group).   
Acute Exercise: To examine the angiogenic responses to acute exercise at each of the 
time points (i.e. Control, D1, D7, D14, D28), half of the mice (n=6/group) performed a 
standardized single 1-hour acute bout of exercise at 20 m/min with 10° incline on a rodent 
treadmill (Columbus Instruments, Exer-6M Treadmill, Columbus, OH), and were then sacrificed 
4 hours after the acute exercise bout. Like the basal muscle expression group, acute exercise 
was performed following a full day without access to the running wheel to minimize any 
response from wheel running exercise.  For all mice, muscle from the left triceps surae 
(gastrocnemius (GA), plantaris (PLT), soleus (SOL)) were extracted for molecular analysis and 
muscle from the right triceps surae for morphometric analysis.   
Maximal Run Test: A maximal running speed test was used to measure aerobic 
performance prior to training, on the final day of training, and one day prior to completion of 
detraining for each respective group. All mice experienced a 24-30 hour rest period (with no 
wheel access) prior to sacrifice examining basal or acute exercise responses. Maximal running 
was performed on a mouse treadmill (Columbus Instruments, Exer-6M Treadmill, Columbus, 
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OH) at a 10° incline. Warm up was 5 minutes at 4 m/min, and then increased by 2 m/min every 
30 seconds until test termination defined by the inability of the animal to continue running on the 
belt despite encouragement. 
Tissue collection and processing. All mice were anesthetized with xylazine/ketamine 
(Ketaject 100mg/kg, Xylazine 5mg/kg) via intraperitoneal injection. Once anesthetized the 
gastrocnemius, plantaris, and soleus muscles from the left leg were carefully removed at its 
respective origin and insertion attachment, weighed, and immediately flash frozen in liquid 
nitrogen for protein analyses. Gastrocnemius, plantaris, and soleus from the right leg were then 
removed in the same manner as the left leg, the mid-belly of the muscles were carefully 
resected and positioned transversely on a cork base and carefully embedded in tissue freezing 
medium (TBS Tissue Freezing MediumTM, Triangle Biomedical Sciences, Durham, NC, USA) 
and immediately flash-frozen in liquid nitrogen cooled isopentane (2-methylbutane, Fisher 
Chemical O3551-4, Fisher Scientific).  All muscle samples were stored at -80 C until processed 
for molecular or morphometric analyses. 
Homogenization: Skeletal muscle was homogenized using a lysis buffer containing 50 
mM Tris/HCl (pH 7.4), 150 mM NaCl, 0.5% Triton X-100, and protease inhibitors (Complete™ 
Tablet, Roche Applied Science, Indianapolis, IN). Homogenates were centrifuged at 4°C, 
14000g for 10 minutes and supernatants were then be removed and placed in new tubes. Total 
protein was measured by the Bradford Assay (Coomassie Plus #23236 Assay Pierce 
Biotechnology, Rockford, IL).  
Protein Analysis: Mouse VEGF, MMP-2, and MMP-9 protein levels were measured from 
100 µg of total protein using a commercially available ELISA kits (VEGF #MMV00, MMP-9 
#MMPT90 from R&D Systems, Minneapolis, MN and MMP-2 #ELM-MMP2-001 from 
RayBiotech, Norcross, GA). All analyses were performed according to the manufacturer's 
specification and optical densities were measured using a microplate reader (Bio Rad Model 
550, Global Medical Instrumentation Inc., Ramsey, Minnesota). For western analysis, samples 
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were denatured (18μg SOL, 39 μg PLT, 39-65μg GA ) and separated on 26 well 8% Bis Tris 
Midi Gel (Novex WG1003BX10, Carlsbad, CA) and blotted onto a 0.45μm nitrocellulose 
membrane (nitrocellulose membrane #88018 Thermo Scientific). Membrane was blocked with 
5% fat-free milk in TBS and then membrane was cut twice to yield three membrane strips (TSP-
1/nucleolin, GAPDH, endostatin) and  probed with respective antibodies TSP-1 
(Thrombospondin 1 (A6.1): sc-59887, Santa Cruz Biotechnology, Santa Cruz, CA); nucleolin 
(nucleolin antibody #A300-711A, Bethyl Laboratories, Montgomery, TX); GAPDH (mouse anti-
GAPDH #39-8600, Invitrogen, Camarillo, CA); endostatin (anti-mouse endostatin antibody 
#AF570 R&D Systems, Minneapolis, MN). Nucleolin was probed after TSP-1 had been 
measured. Equal loading was verified and normalized by the loading control, GAPDH. 
Chemiluminescence detection allowed for visualization of proteins (Pierce ECL Western Blotting 
Substrate, #32209, Rockford, IL), images of blots were taken using Genesnap software (version 
7.01; Syngene). Protein expression was quantified by using NIH ImageJ Software (version 1.62) 
and expressed as densitometric arbitrary units (a.u.). Control samples were loaded on each gel 
to normalize groups.  
Histochemistry. Corks containing frozen muscles embedded in tissue freezing medium 
were cut into serial 8-10 μm transverse sections using a microcyrotome at -20°C (Leica 
CM1850, Leica Biosystems, Buffalo Grove, IL) and mounted on glass slides (Colormark* Plus 
Adhesion Slides, #CM-7951, Thermo Scientific) for histochemical analysis of muscle 
morphometry. Great care was taken to ensure that the widest part of the muscle was sectioned 
and that cuts were made perpendicular to the orientation of the fibers.  Muscle capillarity was 
determined by measuring capillary-to-fiber ratio (C:F) by using the alkaline phosphatase and 
dipeptidylpeptidase capillary staining method (Mrazkova et al., 1986).  Stained muscle sections 
were viewed by light microscopy and digitally imaged at 20x magnification. Muscle capillarity 
was assessed from deep and superficial regions within the gastrocnemius. Deep regions are 
defined as the inner half of the gastrocnemius muscle (closest in proximity to the plantaris and 
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soleus muscles), while superficial regions are comprised of the outer half of the gastrocnemius 
(closest in proximity to the skin). Up to 15 digital images were obtained from each quadrant in a 
pseudo-random selection process. Images were selected if they did not overlap with any 
previous image selected and did not violate the boundary used to demarcate the quadrant being 
imaged. The imaging technician was instructed not to “frame” each image per se, but rather 
accept the random image position (after moving the microscope stage) within each quadrant, 
provided they do not violate the image selection criteria above.   
Statistical Analyses: All data shown are mean ± SEM, unless otherwise indicated.  
Changes in protein expression, exercise performance during training (i.e. daily distance run, 
time running, average speed and maximal speed), and muscle capillarity (i.e. C:F) were 
analyzed using one-way ANOVA. A repeated measure ANOVA was used for multiple measures 
of maximal exercise performance testing. The combined effects of training (i.e. groups trained 
for different days) and the angiogenic factor response to acute exercise (i.e. basal vs. acute 
exercise) for proteins were separately determined using a 2 × 2 factorial ANOVA. When a main 
effect was observed, post hoc testing with a Fisher’s PLSD was used to examine group 
differences. All statistics were performed using Statview Statistical Software package (v5.0.01, 
SAS Institute Inc., Cary, NC). Significance was set at α level of p=0.05.  
 
RESULTS 
Animal body mass and muscle characteristics. There was no significant difference in 
age, body mass or hindlind muscle mass (when normalized to body mass) compared to the 
control group (Table 1).  When compared to control mice, training increased capillary-to-fiber 
ratio (C:F) in the gastrocnemius (p=0.04), plantaris  (p=0.04), and soleus (p=0.04) (Table 1). In 
all muscles, C:F returned to control levels after 7 days of detraining and stayed there with 14 
and 28 days of detraining.   
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Training behavior and aerobic performance.  When comparing voluntary wheel running 
behavior across all groups there was no significant difference in time spent running (ranging 
from an average of 306 to 392 minutes each day, Table 1).  However D14 and D28 mice 
exhibited higher average running speed, average distance run per day, and higher maximal 
wheel training speed compared to D7 mice (p<0.05), but not compared to D1 mice (Table 1).  
Aerobic performance measured by a maximal running test before training, at the end of 
training and at the end of detraining, showed that all groups universally increased maximal 
running speed with training, which returned to control (untrained) levels in all detraining groups 
(Figure 1).  
 
Basal Protein Expresison.   
Gastrocnemius.  Shown in Figure 2a, training (i.e. D1 time point) resulted in an increase 
of basal VEGF (p=0.02) and MMP-9 (p=0.04), all other factors remained unchanged when 
compared to the control group. After 7 days of detraining (D7), VEGF (p<0.01) remained 
elevated and TSP-1 (p<0.01) increased. Following 14 days of detraining (D14), basal VEGF 
(p<0.01) levels were still elevated while TSP-1 fell to baseline. Nucleolin was also significantly 
elevated at D14 compared to controls. At 28 days post training (D28), basal VEGF returned to 
baseline, TSP-1 remained at baseline levels and endostatin (p<0.01), MMP-2 (p<0.01) and 
MMP-9 (p=0.03) had all decreased compared to controls. 
Plantaris.  Shown in Figure 2b, training (D1) resulted in an increase of basal VEGF 
(p<0.01), nucleolin (p=0.03), and TSP-1 (p<0.01).  Endostatin did not change when compared 
to the control group. After 7 days of training (D7), VEGF (p<0.01) and TSP-1 (p<0.01) remained 
elevated.  Nucleolin decreased and endostatin remained unchanged. Following 14 days of 
detraining (D14), VEGF fell to control levels while endostatin (p<0.01) was significantly 
diminished, TSP-1 and nucleolin remained unchanged. At 28 days post training (D28), 
endostatin (p<0.01) remained low, VEGF, TSP-1, and nucleolin were not different from controls. 
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Soleus.  Shown in Figure 2c, training (D1) resulted in a decrease only of endostatin 
(p=0.02) when compared to the control group. After 7 days of detraining (D7), endostatin 
returned to control levels while VEGF (p<0.01), nucleolin (p<0.01), and TSP-1 (p<0.04) were all 
significantly increased. Following 14 days of detraining, endostatin (p<0.01) was increased 
while VEGF, nucleolin and TSP-1 returned to control levels. At 28 days post training VEGF was 
elevated (p<0.01), endostatin (p<0.01) was decreased and TSP-1 and nucleolin were not 
different from control levels.  
 
Protein response to Acute Exercise. 
VEGF protein responded to acute exercise in the control group in the plantaris (p<0.04) 
and soleus (p<0.01), and to a lesser extent in gastrocnemius (Figure 3). This response was 
blunted with training (D1) and remained blunted after 7, 14 or 28 days of detraining in the PLT 
or SOL. Endostatin had a group x acute exercise interaction in the SOL with (p<0.05) and to 
lesser extent in the PLT (p=0.057), but did not have an increase of protein following acute 
exercise in any of the muscles. Nucleolin tended to increase in response to acute exercise in all 
three muscles of control mice, this response was blunted in trained mice, and remained blunted 
with detraining. Furthermore, a significant group x acute exercise interaction (p<0.05) was only 
observed in GA and PLT for nucleolin (Figure 3).  Responses for TSP-1, MMP-2 and MMP-9 
are not reported here because these factors have been shown to respond to acute exercise at 
much later time point (than 4-hours post exercise) used in this study. 
 
DISCUSSION 
The principal finding of this study is that detraining losses in skeletal muscle capillarity, 
occurring after 7 days detraining, are associated with elevated basal expression of TSP-1.  
Surprisingly, basal VEGF protein levels were also elevated after 7-days detraining.  Endostatin 
was not elevated at 7-days post training compared to controls, but rather demonstrated a 
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tendency to decrease with greater time spent detraining.  These data suggest that losses in 
skeletal muscle capillarity (due to physical deconditioning) may be more dependent on the 
expression of TSP-1 and/or other negative regulators, rather than reductions in positive 
angiogenic regulators, such as VEGF.   
 
Training response and muscle capillarization 
Our data show some variability in the voluntary wheel running behavior between mice in 
our respective groups, where D14 and D28 mice exhibit greater daily averages in distance and 
speed compared to D7.  But compared to trained (D1) mice, D14 and D28 were not different. It 
should also be noted that average time spent running was similar across all groups. Importantly, 
the training performed (as assessed in the D1 group) significantly increased muscle capillarity in 
the hindlimb muscles (Table 1) and resulted in similar increases in aerobic performance 
capability for all groups (Figure 1).  These increases universally returned back to baseline levels 
in each detrained group (i.e. D7, D14, D28).  Thus, although it was not possible to measure 
muscle capillarity after training in the D7, D14, or D28 groups, based on the overall running 
behavior and performance it is reasonable to expect similar capillary adaptation to training as 
that seen and reported for D1 (training control) mice. 
Consistent with training induced capillary adaptation, as well as previous reports from 
training studies (Carmeli et al., 2007; Rullman et al., 2009; Huttemann et al., 2012), we 
observed an elevated basal expression of VEGF and MMP-9 in trained (D1) mice, with one 
exception.  VEGF was not elevated in the soleus muscle in D1 mice.  TSP-1 was unchanged in 
trained (D1) mice, except in plantaris muscle.  The lack of elevated basal VEGF in the soleus 
muscle is not surprising and is in line with a study by Birot et al which demonstrated that VEGF 
mRNA was up regulated to a greater extent in type IIb myofibers than type I or IIa, most likely 
due to their glycolytic nature (Birot et al., 2003). The soleus muscle is highly oxidative with a rich 
vascular supply and therefore may not have the same oxygen demand/deficit created by 
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exercise to trigger a significant increase in VEGF as that seen in the plantaris and 
gastrocnemius.   
However, the reason for elevated basal TSP-1 expression in the D1 plantaris, but not the 
gastrocnemius and soleus is less clear.  Previous reports have shown TSP-1 mRNA is 
increased in response to acute exercise, but this response is eventually lost with repeated or 
chronic exercise (Olfert et al., 2006).  Data from our previous training study (unpublished data, 
see Training Study) show no significant difference in basal TSP-1 protein expression in the 
gastrocnemius muscle after 14 to 28 days of voluntary wheel training compared to untrained 
controls, which supports the current observation in the gastrocnemius and soleus muscle of the 
animals in this study. Thus, whether the response in the plantaris is a residual effect of training 
or specific to the plantaris is presently unclear. However, it is possible, as previously noted for 
the VEGF response to training, that this finding could be due the greater glycolytic fiber type 
composition of the plantaris muscle compared to the overall greater oxidative nature seen in the 
soleus and the mixed gastrocnemius muscles.  This is supported by evidence of the lower 
VEGF/TSP-1 ratio (suggesting higher TSP-1 relative to VEGF) reported in plantaris muscle 
compared to the soleus muscle during hindlimb unloading (Roudier et al., 2010).  Greater basal 
TSP-1 protein levels have also been reported in the plantaris compared to gastrocnemius 
(Audet et al., 2011). 
Endostatin was largely unaltered in response to training, except for a decreased 
expression level in the D1 soleus muscle (p<0.05). The lack of response from endostatin is 
consistent with the response in gastrocnemius muscle from our previous Training Study 
(unpublished data, see Training Study). Because the actions of endostatin may be regulated in 
part by nucleolin, we also assessed nucleolin levels in response to detraining. We show that 
nucleolin tends to be up regulated in response to acute exercise, which is in accordance with 
the acute response to exercise we report in our Training Study (unpublished data, see Training 
Study). Training induced (D1) increase in nucleolin was only seen in the plantaris muscle.  An 
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argument could be made to that, this too, may involve the greater glycolytic nature of the 
plantaris and mixed gastrocnemius compared to the more oxidative fiber type composition of the 
soleus muscle. But further studies are needed to examine nucleolin’s role in skeletal muscle 
angiogenesis before the importance and/or contribution of nucleolin will be clearly understood. 
 
Detraining and protein expression in skeletal muscles 
In this study we show similar trends across the muscles examined (GA, PLT, SOL) but 
each muscle also appears to have its own unique temporal response to exercise. In all muscles 
examined, there was a statistically significant increase in basal expression of VEGF and TSP-1, 
concurrent with a decrease in muscle capillarity at after 7 day detraining (D7) compared to 
trained control (D1) mice. We would not have predicted that skeletal muscle capillarity would 
have returned to baseline conditions with elevated VEGF levels given it prominent role in 
stimulating angiogenesis. It curious to note that basal VEGF in the gastrocnemius muscle 
remained elevated (while TSP-1 returned to baseline) after 14 days of detraining, perhaps 
suggesting a window of heighten sensitivity in response to capillary regression and/or 
dependence on a cofactor to trigger new blood vessel growth. Only after 28 days of detraining 
did VEGF return to basal levels. At this same 28 day time point, endostatin, MMP-2, and MMP-9 
were all reduced. We speculate endostatin is likely reduced due to lower MMPs and may serve 
to remove its inhibitory influence in response to acute exercise, and increase the sensitivity of 
VEGF to an exercise stimulus. 
In the plantaris, both endostatin and nucleolin tended to decrease with increasing 
number of days detraining with significantly lower expression at D28 compared to controls 
(Figure 2b).  Unlike the gastrocnemius muscle, after 14 days of detraining, VEGF returned to 
control levels and while endostatin tended to diminished through 28 days of detraining. Although 
VEGF levels are low (not in favor of angiogenesis), endostatin levels are also low (favoring 
angiogenesis) perhaps keeping a balance between positive and negative angiogenic factors. 
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Overall, the plantaris appears to have an accelerated molecular response when compared to 
the gastrocnemius (i.e. VEGF returns to basal levels and endostatin levels are reduced faster 
which may be due to differences in fiber type). Unfortunately, due to small muscle size and 
insufficient sample for analysis, we were not able to measure MMP-2 and MMP-9 in either the 
soleus or plantaris. 
In the soleus, the only protein to be altered by training was endostatin which was 
reduced from D1. Likewise, endostatin levels have been reported to be chronically low in other 
oxidative muscles such as the heart (Gu et al., 2006). It was only after D7 that endostatin 
returned to control levels.  In stark contrast, VEGF, TSP-1 and nucleolin (as seen in the PLT) 
were all significantly up-regulated, suggest that the D7 time point could be a tipping point in the 
soleus with all these proteins at play. After D14, endostatin increased while all other proteins 
that were elevated returned to control levels. At D28, endostatin subsided below control levels 
and VEGF was again elevated.  
Taken together, the main theme that emerges is that TSP-1 may play a prominent role in 
capillary regression associated with detraining. This is consistent with evidence that TSP-1 is 
involved in capillary regression seen during menstrual cycle (Iruela-Arispe et al., 1996; Slater & 
Murphy, 1999).  Here, VEGF is has been shown to be localized in capillaries and was most 
strongly detected in the late proliferative and secretory phase (Bausero et al., 1998) while TSP-
1 has been associated with low capillary growth in the secretory phase (Iruela-Arispe et al., 
1996). So, it may not be unexpected that despite having elevated VEGF levels at D7 in each 
hindlimb muscle examined, muscle capillary was reduced at D7. Unfortunately, the temporal 
resolution of our detraining time course does not allow us to pin point when TSP-1 was first up-
regulated between D1 and D7 or when the reversal of the angiogenic gains made by training 
occurred, but based on these data it is clear that morphological changes in capillarity are fully 
affected by 7 days in this training/detraining paradigm.  
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Response to Acute Exercise Following Detraining  
In the current study, we also evaluated the acute exercise response of angiogenic 
regulators as a means to evaluate the effect of detraining and changes in muscle capillarity—
specifically, when/what are the events that lead to a detrained muscle to return to pre-trained 
conditions. Based on prior evidence (unpublished data, see Training Study), we know that peak 
response for VEGF, endostatin and nucleolin protein expression occurs ~4 hours post exercise, 
therefore this time point was selected to harvest muscle to access angiogenic protein response 
to acute exercise with the temporal response to detraining.  Since the peak protein responses 
for TSP-1, MMP-2, and MMP-9 s did not occur at this time point, there is limited, if any, 
interpretative value to be gained from assessing the acute response of these factors in the 
current study.  
As observed in our Training Study (unpublished data, see Training Study), as well as in 
other publications (Olfert et al., 2001; Hoier et al., 2012), we find acute exercise increases 
skeletal muscle VEGF protein levels in plantaris and soleus muscles.  Surprisingly, this 
response did not prove statistically significant in the gastrocnemius despite a consistent trend 
for VEGF to increase.  Nonetheless, the VEGF response to exercise is well documented in 
literature and is established as a prime process orchestrating skeletal muscle angiogenesis.  
Since it has been reported that responsiveness of VEGF mRNA (Olfert et al., 2001) and protein 
to acute exercise is lost or blunted  with training (Malek et al., 2010), a key question this study 
aimed to answer is when would this acute response to exercise return with detraining. 
Consistent with previous reports, the D1 mice exhibited a blunted (or absent) VEGF protein 
response to acute exercise.  Unexpectedly, the acute VEGF response to exercise never 
significantly reemerged even after 28 days of detraining in any of the muscles, except for one 
case (i.e. D14 in the GA).  This is surprising because an underlying theory for the blunted 
response of VEGF with training was thought to be due to greater number of capillaries (induced 
by training) satisfying the metabolic stress associated with chronic exercise. The present finding 
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argues against this idea suggesting that some other mechanism is likely attenuating the VEGF 
response to acute exercise and keeping it blunt despite the losses of capillaries occurring with 
detraining.   
In contrast to our data, Malek et al. report the acute VEGF response to exercise had 
returned after 7 days of detraining in the plantaris and the soleus muscles of rats who treadmill 
trained 3 days a week for 10 weeks (Malek et al., 2010). In addition to using a different animal 
model from the current study, the training regimen was longer in duration, and used lower 
frequency but higher exercise intensity (50-80% of maximal work rate) than that performed by 
our mice which voluntarily performed high daily frequency but low intensity exercise (at ~34-
40% of their maximal exercise capacity). Thus it could be that high-volume-low-intensity 
exercise has a different effect on angiogenic regulators that low-volume-higher-intensity 
exercise. This notion is supported by recent evidence in humans, where intense intermittent, low 
volume, exercise has been reported to be a weaker stimulus for angiogenesis than constant 
moderate intensity exercise (Hoier et al., 2013). 
 We have previously found that endostatin and nucleolin protein levels were up-regulated 
at 4 hours post-acute exercise, but this was not the case for endostatin in our untrained control 
mice in the present study. In both the gastrocnemius and plantaris, nucleolin demonstrated 
significant group x acute exercise interaction effect (p<0.05) with a tendency of elevated 
response in untrained control mice in all three muscles (Figure 3).  Despite this post-hoc 
analysis for acute response did not prove statistically significant. An explanation for this 
discrepancy between these data and our previous data (unpublished data, see Training Study) 
remains unclear, but could raise questions whether the response of either endostatin or 
nucleolin represents a significant biological response to exercise.  It is important to note, at least 
in the case of endostatin, that it is not a transcriptionally-regulated peptide but rather a fragment 
from a larger extracellular matrix molecule (i.e. collagen XVIII). Thus the inconsistent endostatin 
response we observed could likely be associated with the responses of other factors, such as 
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MMP-2 or MMP-9 which influence proteolytic activity within the extracellular matrix. 
Unfortunately, due to the small mass and total protein available we did not have sufficient 
sample to make an assessment of MMP-2 or MMP-9 in either the plantaris or soleus muscles.      
 
In conclusion, this study has demonstrated the temporal response of key positive and 
negative angiogenic regulators in the gastrocnemius, plantaris, and soleus muscles in response 
to detraining. We have shown that the VEGF protein response to acute exercise remains 
blunted after 28 days of training and that elevated TSP-1 and VEGF expression are associated 
with capillary regression occurring after 7 days of detraining.  These data suggest the 
physiologic regression of muscle capillaries may be influence greater by negative angiogenic 
regulators (such as TSP-1) rather than positive angiogenic regulators (such as VEGF). Future 
studies will be needed to determine when the acute VEGF response to exercise returns, while 
shorter term detraining studies are needed to identify how soon with detraining TSP-1 protein 




Funding support was provided, in part by, West Virginia University Research Funding 
and Development Grant (Olfert), American Heart Association 10BGIA3630002 (Olfert), WVU-
INBRE grant supported by NIH 5P20RR016477 (Olfert & Roberts); and West Virginia University 
Cardiovascular and Respiratory Training Grant NIH 5T32HL090610 (Audet). 





Andersen P & Henriksson J (1977). Capillary supply of the quadriceps femoris muscle of man: 
adaptive response to exercise. J Physiol 270, 677-690. 
 
Audet GN, Meek TH, Garland Jr T & Olfert IM (2011). Expression of angiogenic regulators and 
skeletal muscle capillarity in selectively bred high aerobic capacity mice. Experimental 
Physiology 96, 1138-1150. 
 
Bausero P, Cavaille F, Meduri G, Freitas S & Perrot-Applanat M (1998). Paracrine action of 
vascular endothelial growth factor in the human endometrium: production and target 
sites, and hormonal regulation. Angiogenesis 2, 167-182. 
 
Birot OJ, Koulmann N, Peinnequin A & Bigard XA (2003). Exercise-induced expression of 
vascular endothelial growth factor mRNA in rat skeletal muscle is dependent on fibre 
type. J Physiol 552, 213-221. 
 
Breen EC, Johnson EC, Wagner H, Tseng HM, Sung LA & Wagner PD (1996). Angiogenic 
growth factor mRNA responses in muscle to a single bout of exercise. J Appl Physiol 81, 
355-361. 
 
Carmeli E, Haimovitz T & Nemcovsky EC (2007). Cathepsin D and MMP-9 activity increase 
following a high intensity exercise in hind limb muscles of young rats. J Basic Clin 
Physiol Pharmacol 18, 79-86. 
 
Egginton S (2009). Invited review: activity-induced angiogenesis. Pflugers Arch 457, 963-977. 
 
Folkman J (1995). Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nature 
Med. 1, 27-31. 
 
Gavin TP & Wagner PD (2001). Effect of short-term exercise training on angiogenic growth 
factor gene responses in rat. J. Appl. Physiol. 90, 1219-1226. 
 
Gu J-W, Shparago M, Tan W & Bailey AP (2006). Tissue Endostatin Correlates Inversely with 
Capillary Network in Rat Heart and Skeletal Muscles. Angiogenesis 9, 93-99. 
 
Gustafsson T, Puntschart A, Kaijser L, Jansson E & Sundberg CJ (1999). Exercise-induced 
expression of angiogenesis-related transcription and growth factors in human skeletal 




Haas TL, Milkiewicz M, Davis SJ, Zhou AL, Egginton S, Brown MD, Madri JA & Hudlicka O 
(2000). Matrix metalloproteinase activity is required for activity-induced angiogenesis in 
rat skeletal muscle. Am J Physiol Heart Circ Physiol 279, H1540-1547. 
 
Hanahan D & Folkman J (1996). Patterns and Emerging Mechanisms of the Angiogenic Switch 
during Tumorigenesis. Cell 86, 353-364. 
 
Hoier B, Nordsborg N, Andersen S, Jensen L, Nybo L, Bangsbo J & Hellsten Y (2012). Pro- and 
anti-angiogenic factors in human skeletal muscle in response to acute exercise and 
training. J Physiol 590, 595-606. 
 
Hoier B, Passos M, Bangsbo J & Hellsten Y (2013). Intense intermittent exercise provides weak 
stimulus for vascular endothelial growth factor secretion and capillary growth in skeletal 
muscle. Exp Physiol 98, 585-597. 
 
Hu W, Xia LJ, Chen FH, Wu FR, Tang J, Chen CZ, Jiang S & Chen HH (2012). Recombinant 
human endostatin inhibits adjuvant arthritis by down-regulating VEGF expression and 
suppression of TNF-alpha, IL-1beta production. Inflamm Res 61, 827-835. 
 
Huttemann M, Lee I & Malek MH (2012). (-)-Epicatechin maintains endurance training 
adaptation in mice after 14 days of detraining. Faseb J 26, 1413-1422. 
 
Iruela-Arispe ML, Porter P, Bornstein P & Sage EH (1995). Thrombospondin-1, an inhibitor of 
angiogenesis, is regulated by progesterone in the human endometrium. J. Clin. Invest. 
97, 403-412. 
 
Iruela-Arispe ML, Porter P, Bornstein P & Sage EH (1996). Thrombospondin-1, an inhibitor of 
angiogenesis, is regulated by progesterone in the human endometrium. J Clin Invest 97, 
403-412. 
 
Kim YM, Hwang S, Pyun BJ, Kim TY, Lee ST, Gho YS & Kwon YG (2002). Endostatin blocks 
vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-
1. J Biol Chem 277, 27872-27879. 
 
Kim YM, Jang JW, Lee OH, Yeon J, Choi EY, Kim KW, Lee ST & Kwon YG (2000). Endostatin 
inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic 
activity of matrix metalloproteinase. Cancer Res 60, 5410-5413. 
 
Lapeyre B, Bourbon H & Amalric F (1987). Nucleolin, the major nucleolar protein of growing 
eukaryotic cells: an unusual protein structure revealed by the nucleotide sequence. Proc 




Malek MH & Olfert IM (2009). Global deletion of thrombospondin-1 increases cardiac and 
skeletal muscle capillarity and exercise capacity. Exp Physiol 94, 749-760. 
 
Malek MH, Olfert IM & Esposito F (2010). Detraining losses of skeletal muscle capillarization are 
associated with vascular endothelial growth factor protein expression in rats. Exp Physiol 
95, 359-368. 
 
Mrazkova O, Grim M & Carlson BM (1986). Enzymatic heterogeneity of the capillary bed of rat 
skeletal muscles. Am J Anat 177, 141-148. 
 
Nagase H & Woessner JF, Jr. (1999). Matrix metalloproteinases. J Biol Chem 274, 21491-
21494. 
 
Olfert IM & Birot O (2011). Importance of Anti-angiogenic Factors in the Regulation of Skeletal 
Muscle Angiogenesis. Microcirculation 18, 316-330. 
 
Olfert IM, Breen EC, Gavin TP & Wagner PD (2006). Temporal thrombospondin-1 mRNA 
response in skeletal msucle exposed to acute and chronic exercise. Growth Factors 24, 
253-259. 
 
Olfert IM, Breen EC, Mathieu-Costello O & Wagner PD (2001). Skeletal muscle capillarity and 
angiogenic mRNA levels after exercise training in normoxia and chronic hypoxia. J. Appl. 
Physiol. 91, 1176-1184. 
 
Olfert IM, Howlett RA, Tang K, Dalton ND, Gu Y, Peterson KL, Wagner PD & Breen EC (2009). 
Muscle-specific VEGF deficiency greatly reduces exercise endurance in mice. J Physiol 
578, 1755-1767. 
 
Olfert IM, Howlett RA, Wagner PD & Breen EC (2010). Myocyte vascular endothelial growth 
factor is required for exercise-induced skeletal muscle angiogenesis. Am J Physiol Regul 
Integr Comp Physiol 299, R1059-1067. 
 
Prior BM, Yang HT & Terjung RL (2004). What makes vessels grow with exercise training? J 
Appl Physiol 97, 1119-1128. 
 
Richardson RS, Wagner H, Mudaliar SR, Henry R, Noyszewski EA & Wagner PD (1999). 
Human VEGF gene expression in skeletal muscle: effect of acute normoxic and hypoxic 
exercise. Am J Physiol 277, H2247-2252. 
 
Roudier E, Gineste C, Wazna A, Dehghan K, Desplanches D & Birot O (2010). Angio-
adaptation in unloaded skeletal muscle: new insights into an early and muscle type-




Rullman E, Norrbom J, Stromberg A, Wagsater D, Rundqvist H, Haas T & Gustafsson T (2009). 
Endurance exercise activates matrix metalloproteinases in human skeletal muscle. J 
Appl Physiol 106, 804-812. 
 
Shi H, Huang Y, Zhou H, Song X, Yuan S, Fu Y & Luo Y (2007). Nucleolin is a receptor that 
mediates antiangiogenic and antitumor activity of endostatin. Blood 110, 2899-2906. 
 
Slater M & Murphy CR (1999). Thrombospondin is sequentially expressed and then de-
expressed during early pregnancy in the rat uterus. Histochem J 31, 471-475. 
 
Srivastava M & Pollard HB (1999). Molecular dissection of nucleolin's role in growth and cell 
proliferation: new insights. Faseb J 13, 1911-1922. 
 
Tang K, Breen EC, Gerber HP, Ferrara NM & Wagner PD (2004). Capillary regression in 
vascular endothelial growth factor-deficient skeletal muscle. Physiol Genomics 18, 63-
69. 
 
Volpert OV, Pili R, Sikder HA, Nelius T, Zaichuk T, Morris C, Shiflett CB, Devlin MK, Conant K & 
Alani RM (2002). Id1 regulates angiogenesis through transcriptional repression of 
thrombospondin-1. Cancer Cell 2, 473-483. 
 
Yamaguchi N, Anand-Apte B, Lee M, Sasaki T, Fukai N, Shapiro R, Que I, Lowik C, Timpl R & 
Olsen BR (1999). Endostatin inhibits VEGF-induced endothelial cell migration and tumor 















Figure 1. Maximal running test showing aerobic exercise capacity prior to training (pre-
training), post-training and after detraining.  Measured using a standardized incremental 
maximal exercise protocol on a rodent treadmill. *p<0.05 compared to pre-training. Data are 
mean ± SE.  
Figure 2. Basal protein expression of vascular endothelia growth factor (VEGF), 
thrombospondin-1 (TSP-1; 165kDa), matrix metalloproteinase (MMP)-2, MMP-9, endostatin 
(22kDa) and nucleolin (100kDa)  in the (a) gastrocnemius, (b) plantaris and (c) soleus muscles 
measured by ELISA or Western Blot. Representative blots are shown. Control mice did not 
train, all others voluntarily trained on running wheels for 21 days and then subsequently 
detrained for 1, 7, 14, or 28 days (D1, D7, D14, D28, respectively). a.u.= arbitary densitometry 
units from Western blot analysis for each respective factor which has been normalized to the 
housekeeping gene GAPDH or β-tubulin.  *p<0.05 compared to control. Data are mean ± SE.  
Figure 3. Fold-change in protein expression in response to acute exercise for VEGF, 
endostatin (22kDa) and nucleolin (100kDa) in the gastrocnemius, plantaris, and soleus following 
the same conditions in Figure 2. These proteins (VEGF, endostatin and nucleolin ) were 
selected due to their increased expression 4 hours post acute exercise in the Training Study 
(Chapter 2). The basal protein expression in each group of mice was set to 1.0 showing the 
relative acute/basal protein change by group. Data reflect protein levels 4 hours post acute 























































   
































                            Figure 3. 
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TABLE 1 Control 
Days Detraining 























Average Running Time per day 
(min)  
n/a   332 ± 24 306 ± 52 392 ± 52 358 ± 24 
Average Distance Run per day (km) 
 
n/a   6 ± 0.6 4.5 ± 0.4 7.5 ± 0.6 † 7.1 ± 0.8 † 
Average Running Speed (km/hr) 
 






Maximum Running Speed (km/hr) 
 























Age (days) 106 ± 0.1 105 ± 0 104 ± 0 102 ± 0 110 ± 0 
Body Mass, BM (g) 27.2 ± 0.5 27.9 ± 0.4 27.2 ± 0.4 26.5 ± 0.4 27.4 ± 0.8 
Gastrocnemius muscle, GA (mg) 148.5 ± 3.8 148.3 ± 3.3 146 ± 2.7 143.1 ± 2.4 145.4 ± 3.5 
Plantaris muscle, PLT (mg) 21.1 ± 0.7 22 ± 0.8 20.4 ± 0.5 20 ± 0.5 20.5 ± 0.6 
Soleus muscle, SOL (mg) 8.8 ± 0.4 10.3 ± 0.4 8.8 ± 0.4 8.7 ± 0.2 8.7 ± 0.5 
GA/BM (%) 0.55 ± 0.01 0.53 ± 0.01 0.54 ± 0.01 0.54 ± 0.01 0.53 ± 0.01 
PLT/BM (%) 0.08 ± 0.003 0.08 ± 0.003 0.08 ± 0.002 0.08 ± 0.001 0.08 ± 0.002 












GA C:F 1.37 ± 0.04 1.66 ± 0.16 * 1.2 ± 0.08 ‡ 1.3 ± 0.07 ‡ 1.35 ± 0.11 ‡ 
PLT C:F 1.26 ± 0.04 1.44 ± 0.05 * 1.17 ± 0.05 ‡ 1.28 ± 0.08 1.1 ± 0.10 ‡ 
SOL C:F 1.61 ± 0.07 1.81 ± 0.01 * 1.62 ± 0.03 ‡ 1.72 ± 0.07 1.53 ± 0.05 ‡ 
                                
 Mean±SEM. n/a, not applicable; C:F, capillary-to-fiber ratio.  p<0.05; ‡ different compared to control; * different compared to D1;  † different compared to D7. 
 
     
 
             
    Table 1. Characterization of wheel running over 21 days, age, body mass, muscle mass and C:F ratio. 
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CHAPTER 4: CONCLUSION 
Conclusions 
This work evaluated the temporal response of several positive and negative angiogenic 
proteins in response to acute exercise, training and detraining in skeletal muscle of mice. We 
find and report a complex interplay between positive and negative angiogenic factors in 
response to these physiologic conditions resulting in capillary growth (training) and regression 
(detraining).  
 
Temporal Response to Acute Exercise 
We observed that acute exercise elicited a response of VEGF, MMP-2, TSP-1, 
endostatin and nucleolin proteins, but no significant response was reported for MMP-9 up to 24 
hours post exercise. These results were in agreement with our initial hypothesis that both 
positive and negative angiogenic factors would be up-regulated. We find that angioregulatory 
proteins were markedly up-regulated in either an early (2-4 hours; VEGF, endostatin, nucleolin) 
or late (12-24 hours; MMP-2 and a lesser extent TSP-1) phase in the 24 hour time course. We 
are the first to show that nucleolin, a nuclear protein that may assist in the intracellular transport 
of VEGF and/or endostatin, may also be responsive to acute exercise.  The role of nucleolin in 
exercise is novel and could provide a link between VEGF and endostatin regulation in response 
to acute exercise. In both, our Training (Chapter 2) and Detraining Studies (Chapter 3) we 
observed a consistent and robust VEGF protein response to acute exercise in untrained mice.  
Surprisingly, the response of both endostatin and nucleolin were much more variable in our 
Training (Chapter 2) and Detraining Studies (Chapter 3).  In the Training Study (Chapter 2), 
although both proteins were upregulated in the acute exercise time course, neither endostatin 
nor nucleolin responded to acute exercise in the control mice for the training portion of the 
study.  However, in the Detraining Study (Chapter 3), we find evidence that nucleolin responded 
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to acute exercise, but endostatin still did not respond.   Perhaps these proteins are more 
sensitive to the relative exercise workload for each mouse. Given the variability in the responses 
for both nucleolin and endostatin, the overall importance of these factors may still be somewhat 
speculative.  
We expected a more robust TSP-1 protein response to acute exercise based on its 
known mRNA response, but TSP-1 tended to only be elevated late (up to 24 hours) post 
exercise.  Likewise, we saw no response for MMP-9, which also was surprising since other 
studies have reported MMP-9 to increase within a few hours following acute exercise in different 
animal models. Discrepancies between our data and others may be in part explained by 
exercise intensity and species type. Nonetheless, we find clear evidence supporting our 
hypothesis that both positive and negative angiogenic factors are up-regulated in response to 
acute exercise, suggesting an internal system designed to limit and/or prevent unnecessary 
utilization of energy and biological resources for capillary expansion in response to a single, 
one-time, stimulus.  
  
Temporal Response to Training 
 The goal of our Training Study was to temporally evaluate and link changes in 
angiogenic regulators with changes to training  induced capillary adaptation.  We found that 
voluntary wheel running increased muscle capillarity after at 7 days. In agreement with our 
hypothesis, basal expression of positive factors remained elevated while basal expression of 
negative factors decreased with increasing temporal exposure to training. In response to our 
hypothesis, nucleolin and VEGF were significantly higher at 5 and 7 days respectively while 
TSP-1 was diminished at days 5 and 7, relative to days 14 and 28 of training; these two time 
points correlate with a significant increase in skeletal muscle capillarity at day 7. Contrary to our 
hypothesis, positive factors did not remain elevated, nor did negative factors decrease with 
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increasing training; by day 28 VEGF was significantly lower and TSP-1 was significantly higher 
than it was at days 5 or 7. Retrospectively, this inverse of the angiogenic balance is feasible 
because once the skeletal muscle has adapted to the increased demand for oxygen created 
during exercise, there could likely be negative feedback to inhibit/reduce the continual growth of 
vasculature. Other angiogenic factors investigated in response to training were MMP-9, MMP-2 
and endostatin. MMP-9 and MMP-2 were down (relative to control) and up (relative to day 3) 
respectively at days 5, 7 and 14; however, previous literature would suggest that MMP-9 should 
have been up-regulated at day 3.  This discrepancy might be accounted for by exercise intensity 
and animal models used. Endostatin was not significantly altered with training.  
Furthermore, we hypothesized that acute exercise would result in a blunting or loss of 
the positive, but not negative, angiogenic regulator response following exercise training.   In 
response to this hypothesis, the acute response to VEGF was present at day 3 and remained 
elevated after 5 days of training.  Given the response for endostatin and nucleolin in our 
previous acute temporal exercise response, we were surprised that neither factor was increased 
in the control group of the training study. At present, the reason for this remains unclear.  Given 
that muscles were sampled in early phase (i.e 4 hours) post exercise, we would not expect 
TSP-1 or the MMP-2 to respond.  
Taken together, it can be concluded that angiognesis resulting from exercise training 
occurs in association with basal changes of both positive (VEGF, MMP-2, nucleolin) and 
negative (TSP-1) angiogenic regulators. Given the differences observed in these proteins 
between humans and mice, these data also highlight the temporal responses we observed in 
mice (particularly for VEGF, MMP-2 and MMP-9) may not be directly comparable to humans. 
Nonetheless, it is clear our results show that there is a complex coordination in the protein 
responses of both positive and negative angiogenic factors that correspond with training-




Temporal Response to Detraining 
The goal of the Detraining Study was to temporally link changes in angiogenic regulators 
with capillary regression associated with physical deconditioning (i.e. detraining).  We 
hypothesized there would be in increase of negative, relative to positive angiogenic factors with 
detraining.  In agreement with our hypothesis, we found TSP-1 protein was increased at 7 days 
post training in all the skeletal muscle examined.  At this same time point, skeletal muscle 
capillarity returned to baseline (pre-training levels) despite elevated VEGF protein. We also 
hypothesized that the acute response to exercise would return once capillarity reached pre-
training levels. To our surprise, this was not the case since 28 days of detraining was not 
sufficient time for the well-established VEGF response to acute exercise to reappear. Finally, we 
hypothesized that oxidative muscles would have greater changes in angiogenic regulators (both 
positive and negative) compared to glycolytic muscles. We show there are protein expression 
differences between glycolytic and oxidative muscles after training (D1); TSP-1, VEGF and 
nucleolin were all elevated after 1 day of detraining relative to the control group in the plantaris 
but not the soleus.  However, all muscles (GA, PLT, SOL) had the same increase of both TSP-1 
and VEGF protein at 7 days post training (D7), the same time point as capillary regression. We 
also show a trend for a decrease of endostatin with time spent detraining in all muscles.  In 
conclusion, these data suggest that although detraining responses after 1 day of detraining may 
be different among the oxidative and glycolytic muscles, all muscles exhibited physiologic 
regression of skeletal muscle capillary regression by 7 days of detraining which may be due to a 
greater influence of negative regulators (TSP-1) than positive regulators (VEGF) following 
detraining. Furthermore, we have shown that the VEGF protein response to acute exercise 
remained blunted after 28 days of detraining.  
 
In conclusion, our findings suggest that skeletal muscle angiogenesis is a complex 
interplay involving both positive and negative angiogenic factors whose expression profiles are 
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temporally distinct in response to acute exercise.  And, whose relative importance may be 
different in response to training-induced capillary expansion compared to detraining-induced 
capillary regression.  Future temporal studies investigating additional angiogenic factors may 
assist in clarifying the mechanisms underlying changes in skeletal muscle capillarity which will 
aid in promoting our understanding of capillary growth and regression under physiologic 
conditions, but also lay the foundation to better understand the reasons for capillary rarefaction 
in chronic disease such as chronic obstruction pulmonary disease, diabetes and/or heart 
disease.  
 
